0001548123-17-000202.txt : 20170814 0001548123-17-000202.hdr.sgml : 20170814 20170814151725 ACCESSION NUMBER: 0001548123-17-000202 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170814 DATE AS OF CHANGE: 20170814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLEXPOINT SENSOR SYSTEMS INC CENTRAL INDEX KEY: 0000925660 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 870620425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-24368 FILM NUMBER: 171029636 BUSINESS ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 8015685111 MAIL ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: MICROPOINT INC DATE OF NAME CHANGE: 19980424 FORMER COMPANY: FORMER CONFORMED NAME: NANOTECH CORP DATE OF NAME CHANGE: 19940620 10-Q 1 flxt10qq220172v4.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2017 10QSB 1 flx06q3e

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For quarterly period ended June 30, 2017


[   ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _____ to _____


Commission file number: No. 0-24368


FLEXPOINT SENSOR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)


Delaware

87-0620425

 (State of incorporation)

(I.R.S.  Employer Identification No.)

     

106 West 12200 South, Draper, Utah  84020

(Address of principal executive offices)


801-568-5111

(Registrant’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  

Yes [X]   No [   ]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [X]   No [   ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,”  “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer [   ]

Non-accelerated filer [   ]

Accelerated filer [   ]

Smaller reporting company [X]

Emerging growth company [   ]


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [   ]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.

Yes [   ]     No [X]


The number of shares outstanding of the registrant’s common stock was 78,363,464 as of August 14, 2017.




TABLE OF CONTENTS


PART I: FINANCIAL INFORMATION


Item 1.

Condensed Financial Statements

 

 

 

 

Condensed Consolidated Balance Sheets (Unaudited) at June 30, 2017 and

3

 

 

December 31, 2016 (Audited)

 

 

 

 

Condensed Consolidated Statements of Operations (Unaudited) for the Three

4

 

 

And Six Months Ended June 30, 2017 and 2016

 

 

 

 

Condensed Consolidated Statements of Cash Flows (Unaudited) for the

5

 

 

Six Months Ended June 30, 2017 and 2016

 

 

 

 

Notes to Condensed Consolidated Financial Statements (Unaudited)

6

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12

 

 

Item 3.

Quantitative and Qualitative Disclosure about Market Risk

17

 

 

Item 4.

Controls and Procedures

17


PART II: OTHER INFORMATION


Item 1.  

Legal Proceedings

18

 

 

 

Item 1A.

Risk Factors

18

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

19

 

 

 

Item 3.

Defaults upon Senior Securities

19

 

 

 

Item 4

Mine Safety Disclosures

19

 

 

 

Item 5.

Other Information

19

 

 

 

Item 6.

Exhibits

20

 

 

Signatures

21





PART I - FINANCIAL INFORMATION


ITEM 1.  CONDENSED FINANCIAL STATEMENTS


The financial information set forth below with respect to our condensed consolidated financial position as of June 30, 2017, the condensed consolidated statements of operations for the three and six months ended June 30, 2017 and 2016, and cash flows for the six months ended June 30, 2017 and 2016 are unaudited. The information presented below for the condensed consolidated financial position as of December 31, 2016 was audited and reported as part of our annual filing of our Form 10-K, filed with Securities and Exchange Commission on April 18, 2017.  The results of operations for the three and six  months ended June 30, 2017 and 2016, respectively, are not necessarily indicative of results to be expected for any subsequent periods.




2





FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED BALANCE SHEETS


 

 June 30,

2017 (Unaudited)

 

December 31, 2016

(Audited)

ASSETS

 

 

 

Current Assets

 

 

 

Cash and cash equivalents


$             686

 

 $                -

Accounts receivable, net of allowance for bad debts of $102,140

    and $102,140

119,249

 

            84,499

Deposits and prepaid expenses

9,368

 

            9,348

Total Current Assets

129,303

 

          93,847

Long-Term Deposits

6,550

 

              6,550

Property and Equipment, net of accumulated depreciation

 

 

 

    of $587,886 and $586,787

               9,704

 

             10,823

Patents and Proprietary Technology, net of accumulated

 

 

 

amortization of $906,571 and $876,037

65,824

 

           96,358

Goodwill

4,896,917

 

        4,896,917

Total Assets

$   5,108,301

 

 $     5,104,495

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current Liabilities

 

 

 

Accounts payable

 $      186,279

 

 $       172,602

Accounts payable - related party

15,594

 

                1,420

Accrued liabilities

975,449

 

          741,778

Convertible notes payable

1,324,660

 

         1,184,660

Convertible notes payable to related party, net

35,046

 

            20,000

Derivative liabilities

116,342

 

76,295

   Total current liabilities

2,653,370

 

2,196,755

Long-term Liabilities

 

 

 

Convertible notes payable, net

22,272

 

-

Total Liabilities

2,675,642

 

    2,196,755

 

 

 

 

Stockholders' Equity

 

 

 

Preferred stock – $0.001 par value; 1,000,000 shares authorized;

 

 

 

no shares issued or outstanding

                  -

 

                  -

Common stock – $0.001 par value; 100,000,000 shares authorized;

 

 

78,363,464 shares and 78,363,464  shares issued and

outstanding

78,363

 

            78,363

Additional paid-in capital

29,062,078

 

     29,052,188

Accumulated deficit

(26,707,782)

 

    (26,222,811)

Total Stockholders' Equity

2,432,659

 

        2,907,740

Total Liabilities and Stockholders' Equity

$  5,108,301

 

 $     5,104,495



The accompanying notes are an integral part of these condensed consolidated financial statements



3




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)


 

 

For the Three Months

 

For the Six Months

 

 

Ended June 30,

 

Ended June 30,

 

 

2017

 

2016

 

2017

 

2016

 

 

 

 

 

 

 

 

 

Design, Contract and Testing  Revenue

 

$        154,636

 

$        93,039

 

$        215,701

 

$        128,205

 

 

 

 

 

 

 

 

 

Operating Costs and Expenses

 

 

 

 

 

 

 

 

Amortization of patents and proprietary       

 

 

 

 

 

 

 

 

    proprietary technology

 

           12,110

 

           22,346

 

           30,533

 

           46,087

 Cost of revenue

 

    30,892

 

    1,166

 

34,641

 

2,510

Administrative and marketing expense

 

         189,738

 

         175,935

 

         354,851

 

         353,356

Research and development expense

 

           85,143

 

           79,281

 

         164,509

 

         159,340

 

 

 

 

 

 

 

 

 

Total Operating Costs and Expenses

 

         317,883

 

         278,728

 

         584,534

 

         561,293

 

 

 

 

 

 

 

 

 

Net Operating Loss

 

(163,247)

 

(185,689)

 

(368,833)

 

(433,088)

 

 

 

 

 

 

 

 

 

Other Income and Expenses

 

 

 

 

 

 

 

 

Interest expense

 

        (63,730)

 

(230,707)

 

(165,340)

 

    (454,598)

Interest income

 

11

 

1,915

 

23

 

3,830

Gain(Loss) on derivative

 

33,492

 

--

 

            49,179

 

             --

 

 

 

 

 

 

 

 

 

Net Other Income (Expense)

 

        (30,227)

 

    (228,792)

 

   (116,138)

 

   (450,768)

 

 

 

 

 

 

 

 

 

Net Loss

 

$     (193,474)

 

$     (414,481)

 

 

$     (484,971)

 

 

$     (883,856)

 

 

 

 

 

 

 

 

 

Basic and Diluted Loss per Common Share

$           (0.00)

 

$           (0.01)

 


$           (0.01)

 


$           (0.01)

 

 

 

 

 

 

 

 

 

Basic and Diluted Weighted-Average

 

 

 

 

 

 

 

 

    Common Shares Outstanding

 

    78,363,464

 

    71,627,114

 

    78,363,464

 

    71,627,114




 The accompanying notes are an integral part of these condensed consolidated financial statements




4




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)


 

 

 

For the Six Months

 

Ended June 30,

 

2017

 

2016

 Cash Flows from Operating Activities: 

 

 

 

    Net loss

$   (484,971)

 

$   (883,856)

    Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

        Stock subscription for compensation

--

 

1,000

        Stock-based compensation expense

9,890

 

16,802

        Amortization of patents and proprietary technology

30,533

 

46,087

        Amortization of discount on note payable

3,246

 

405,521

        Depreciation

1,120

 

--

        Change in fair value of derivative liabilities

(49,179)

 

--

        Interest expense recognized for derivative liabilities

63,298

 

--

   Changes in operating assets and liabilities:

 

 

 

        Accounts receivable

(34,750)

 

(85,527)

        Deposits and prepaid expenses

(20)

 

2,625

        Accounts payable

           13,674

 

7,943

        Accounts payable – related parties

14,174

 

516

        Accrued liabilities

             214,604

 

186,892

 Net Cash Used in Operating Activities 

(218,381)

 

(301,997)

 

 

 

 

 Cash Flows from Investing Activities: 

 

 

 

       Note receivable interest income

--

 

(3,807)

 Net Cash Used in Investing Activities 

--

 

(3,807)


 Cash Flows from Financing Activities:

 

 

 

        Proceeds from bank overdrafts

19,067

 

35,870

        Proceeds from borrowings under convertible note payable – related party

20,000

 

--

        Proceeds from borrowings under convertible note payable

180,000

 

250,000

 Net Cash Provided by Financing Activities 

219,667

 

285,870

 

 

 

 

 Net Change in Cash and Cash Equivalents

686

 

(19,934)

 Cash and Cash Equivalents at Beginning of Period

--

 

             22,706

 Cash and Cash Equivalents at End of Period

$                686 

 

$         2,772

 

 

 

 

 Supplemental Cash Flow Information:

 

 

 

    Cash paid for income taxes

$                   -- 

 

$                -- 

    Cash paid for interest

$                   -- 

 

 $                -- 

   Supplemental Disclosure on Noncash Investing and Financing Activities

 

 

 

    Recognition of discounts on convertible notes payable

$            25,928

 

$         56,750












The accompanying notes are an integral part of these condensed consolidated financial statements



5




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)


NOTE 1SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.


Nature of Operations – Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company’s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company’s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through June 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.


Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates.


Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.


Fair Value MeasurementsThe fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party’s own credit risk.

 

Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.



6




 

The carrying value of the Company’s cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.

 

The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.


Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances.  The balance in the allowance account was $102,140 and $102,140 in the periods ended June 30, 2017 and December 31, 2016, respectively.  


Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.


Valuation of Long-lived Assets – The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the period ended June 30, 2017 and during the period ended June 30, 2016.  Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.


Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.  Under similar analysis there was no impairment charge taken during the period ended June 30, 2017 and during the period ended June 30, 2016.


Research and Development – Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.


Goodwill – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or “ASC”) 350-20 Intangibles – Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company’s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.


Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts



7




are met and then recognized as licensing royalty revenue over the remaining term of the contracts.  The Company does not provide extended warranties or guarantees on its products.


Stock-Based Compensation – The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.   All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended June 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $9,890 and $16,802, respectively.


Basic and Diluted Loss Per Share – Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At June 30, 2017 and June 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 27,986,602 and 21,648,704, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.


Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable.  During the six month period ended June 30, 2017, a customer who manufacturers toys represented 45% of sales and represented 11% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.  


Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized


Recent Accounting Pronouncements - In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-09, "Stock Compensation - Scope of Modification Accounting". This ASU requires all modifications to be accounted for as a modification unless the fair value, vesting conditions and classification of the award as equity or liability are the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective for fiscal years beginning after December 15, 2017 and for interim periods therein. The Company does not believe this ASU will have a material impact on its consolidated financial position, results of operation or cash flows.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.


NOTE 2 – GOING CONCERN


The Company continues to accumulate significant operating losses and has an accumulated deficit of $26,707,782 at June 30, 2017.  These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. The Company has relied on raising additional capital through the issuance of convertible notes payable; however, there is no assurance that additional funding will be available on acceptable terms, if at all.


NOTE 3 – DERIVATIVE INSTRUMENTS


The derivative liability as of June 30, 2017, in the amount of $116,342 has a Level 3 fair value classification.

 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of June 30, 2017 and December 31, 2016:

 



8





 

 

 

 

Total

 

Balance, December 31, 2015

 

 

 

 

-

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

40,892

 

Change in fair value of derivative liabilities

 

 

 

 

35,403

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, December 31, 2016

 

 

 

 

76,295

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

89,226-

 

Change in fair value of derivative liabilities

 

 

 

 

(49,179)

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, June 30, 2017

 

 

 

 

116,342

 

 

During the year ended 2016 and the period ended June 30, 2017, the Company issued convertible promissory notes which are convertible into common stock. Due to the Company’s lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle all convertible instruments.  The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.

 

At June 30, 2017, the Company marked to market the fair value of the derivatives and determined a fair value of $116,342. The Company recorded a gain from change in fair value of derivatives of $49,179 for the six month period ended June 30, 2017. During the six months ended June 30, 2017, the Company recorded additional interest expense of $63,298 and debt discounts of $25,928 in connection with the recognition of derivative liabilities. The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 114.57% to 128.15%, (3) weighted average risk-free interest rate of 0.76% to 1.14% (4) expected life of 0.50 to 1.08 years, and (5) the quoted market price of the Company’s common stock at each valuation date.

 

In accordance ASC 840-15-25, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.

  

As of June 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:


 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

Derivative Liabilities

 

 

-

 

 

 

-

 

 

 

116,342

 

 

 

116,342

Total

 

$

-

 

 

$

-

 

 

$

116,342

 

 

$

116,342


Convertible Notes Payable


The Company entered into a new promissory note for up to $300,000 from a third party on May 25, 2017.  The note has an annual interest rate of 10% and is secured by the Company’s equipment.  The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of July 31, 2018.  The Company drew $40,000 against that note on June 2, 2017 and $40,000 on July 13, 2017.   


The Company entered into a convertible promissory note for up to $300,000 from a third party on July 1, 2016.  The note has an annual interest rate of 10% and is secured by the Company’s equipment.  The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.  The Company drew $160,000 against that note during 2016 and $40,000 on January 6, 2017;  $40,000 on January 31, 2017 $40,000 on March 7, 2017 and the balance of $20,000 on April 28, 2017.


On August 8, 2011, the Company entered into a convertible note payable with a former Company Director for $40,000. This note was due on December 31, 2015, bears an annual interest rate of 10% annual interest and is secured by business equipment.





9




Convertible Note Payable Related Party


On April 17, 2017 the Company issued a note for $20,000 to an officer of the Company.  The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2017.  The note is secured by all of the Company’s business equipment.


On July 1, 2016 and September 22, 2016, the Company issued two promissory notes for $10,000 each to an officer of the Company.  The notes bear interest at the rate of 10%, have a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.  Since the fair value of the common stock at the date of the July 1, 2016 advance was $0.07, no BCF was recorded.


NOTE 4 STOCK OPTION PLANS


On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted

closing market price of the Company’s trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the

plan is 2,500,000 shares.  The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under

ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.


On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company’s common stock.  Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees.  Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share.  Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively.  We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.


Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.  Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share.  The options vest over three years and expire 10 years from the date of grant.  The Company used the following assumptions in estimating the fair value of the options granted:


·

Market value at the time of issuance – Range of $0.14 to 2.07

·

Expected term – Range of 3.7 years to 10.0 years

·

Risk-free interest rate – Range of 1.60% to 4.93%

·

Dividend yield – 0%

·

Expected volatility – 200% to 424%

·

Weighted-average fair value - $0.16 to $2.07


During the six months ended June 30, 2017, the Company recognized a total of $9,890 of stock-based compensation expense, leaving $10,052 in unrecognized expense as of June 30, 2017. During the six months ended June 30, 2016, the Company recognized $16,802 in stock-based compensation expense. There were 2,185,000 and 2,185,000 employee stock options outstanding at June 30, 2017 and December 31, 2016, respectively.  


A summary of all employee options outstanding and exercisable under the plan as of June 30, 2017, and changes during the three months then ended is set forth below:





10





Options

Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual  Life (Years)

Aggregate Intrinsic Value

 

 

 

 

 

Outstanding at the beginning of period

         2,185,000

 $                0.16

             8.66

 $              --   

   Granted

--

--

                   --   

                 --   

   Expired

                     --

                             --

                   --   

                 --   

   Forfeited

--

--

                   --   

                --   

Outstanding at the end of Period

       2,185,000

 $                 0.17

             8.16

$               --   

Exercisable at the end of Period

1,836,667

 $                 0.17

             8.16

$               --   


NOTE 4 – CAPITAL STOCK


Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized.  At June 30, 2017 and December 31, 2016, there were no shares of preferred stock issued or outstanding.


Common Stock – There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized.  No shares of stock were issued during the six months ended June 30, 2017.  


NOTE 5 - COMMITMENTS AND CONTINGENCIES


The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017.  Either party may terminate the lease upon 90 day written notice.  Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), $9,300 per month in 2016 and $9,600 per month in 2017.


NOTE 6 – RELATED PARTY TRANSACTIONS


At June 30, 2017 and December 31, 2016, the Company had accounts payable of $15,594 and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.


NOTE 7- SUBSEQUENT EVENTS


On July 13, 2017 the Company drew $40,000 against a convertible promissory note for up to $300,000 from a third party, the proceeds of which will be used to fund operating expenses. The note has an annual interest rate of 10% and is secured by the Company’s equipment. The note has a conversion feature for restricted common shares at $.07 per share.  




















11




In this quarterly report references to “Flexpoint", "the Company," “we,” “us,” and “our” refer to Flexpoint Sensor Systems, Inc. and its subsidiaries.



FORWARD LOOKING STATEMENTS


The U.S. Securities and Exchange Commission (“SEC”) encourages reporting companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions.  This report contains these types of statements. Words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements.  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.


ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


EXECUTIVE OVERVIEW


Flexpoint Sensor Systems, Inc. is principally engaged in designing, engineering and manufacturing bend sensor technology and products using Bend Sensor® technology, (a flexible potentiometer technology).  We continue to make further improvements to our technologies, manufacturing and developing fully integrated devices and related products that we have been marketing and selling to a variety of companies in diverse industries.  We are negotiating and signing agreements and contracts that have provided some limited revenues and have proven that our sensors are more durable, adaptable and cost effective than any other product currently on the market.  We own five patents, including patents on specific devices that use the Bend Sensor® and have exclusive rights through licensing agreements to other patents and devices.  


We are continuing to develop and enhance our intellectual properties that will result in additional patents being filed. The Company currently manufactures, and has jointly developed, eighteen products that are being sold and supplied to current customers and we continue to receive orders for custom prototype sensors as well as our standard sensors.  Our sales and marketing efforts have been targeted toward the development of new relationships with clients while maintaining and strengthening relationships already developed with several Tier 1 (major) suppliers in the automotive industry.  We have built and shipped orders to a number of these companies to enable them to test the utilization of our sensors into their existing and developing product lines.  During 2017 we plan to focus our marketing efforts on a number of larger domestic and international companies that have applications which have the potential to greatly increase the volume of sensors we are currently manufacturing.


The Company continues to develop relationships in a number of application fields.  In July we announced a strategic relationship with HTK Safety to begin offering an integrated safety system utilizing the Bend Sensor® technology.  In March 2017 we announced a collaborative working arrangement with 11 Health and Technologies Inc. to develop next generation products in the medical industry.  Flexpoint has also established relationships with several other medical IoT vendors.  These include companies like 11Health, Neofect, Gloreha and YouReHab; all with a focus on medical rehabilitation with a different approach.  Products from these companies range from gloves to prosthetics to virtual reality, all with the intention of improving medical health or medical rehab.  Medical IoT sensor volume is expected to be more than 50,000 sensors in 2017.


In March 2017 we announced a collaborative relationship with CaptoGlove, a company which manufactures a wearable virtual reality gaming motion controller.  Our companies will work together to deliver innovative, integrated virtual reality/augmented reality (“VR/AR”) systems to mass markets.  We completed and shipped the initial portion of the order before the end of the second quarter and expect to complete and ship the entire order before the end of the year.  Their ground-breaking glove systems, combined with unique, leading edge software applications, also adapt to a wide range or other applications, including health rehabilitation, unmanned systems control, smartphone interaction and professional training across multiple industries.  


ManusVR, CaptoGlove and Virtual Motion Labs have products that are currently commercially available and feature the Flexpoint Bend Sensor®.   A few other companies in this market are expected to release Bend Sensor®



12




products in 2017. Flexpoint expects the purchase orders that are currently being fulfilled for ManusVR and CaptoGlove to significantly ramp up in volume and frequency throughout 2017.  Flexpoint has received orders for more than 150,000 sensors and related assemblies from multiple development partners around the globe. The Company began to fulfill the orders in the second quarter of 2017 and complete fulfillment is expected before year end.  Based upon the increased orders, management expects significant revenue growth within the next six to twelve months. Demand continues to grow and the Company expects to receive increasingly larger volume orders before yearend and continuing into 2018.


Purchase orders were also received this quarter from NoDNA GmbH, a new customer who provides advanced robotics solutions.  This customer serves an expanding global customer base comprised of professional organizations, governmental entities and their sub-suppliers, as well as hobbyists and entrepreneurs.


The Company began selling and distributing sensors through two resellers in 2016.  Flexpoint has since greatly increased its relationships with resellers and is currently working with seven resellers across diverse industries. Some of these companies include Amazon, NoDNA, RobotShop, Karlsson Robotics, SPI and Infusion Systems.  We are receiving recurring sales from these resellers with most experiencing a growing number of sensors ordered each time.   We anticipate that sensor volume sold in 2017 through these channels should approach 25,000.


The biggest revenue contributors during the 2017 six month period were for glove based products and the toy relationship.  Flexpoint, year-to-date, has delivered on approximately 150,000 sensors for its partnership with the toy manufacturer.  The Company expects annualized volumes for 2017 to be approximately a half a million sensors. Sensor volume from glove based applications is expected to exceed 175,000 in 2017.  


Our patented technology continues to gain recognition in various markets and industries as evidenced by orders from a Fortune 100 automotive maker for our horn system.  Although, so far the volumes for our applications and devises have been relatively small we continue to receive follow up orders for the universal sensor that we jointly developed. We expect to receive additional orders from other customers for this sensor as it becomes more recognizable in the market. Currently our customers for this type of sensor include companies in the following industries: automobiles, trucking, emergency vehicles, public transportation, military and other governmental entities. As anticipated, the Company is beginning to see the potential for more significant volumes and revenues from the sale of this sensing devise over the next year and beyond.


Finalizing additional long-term revenue generating production contracts with other customers remains our greatest challenge because our on-going business is dependent on the types of revenues and cash flows generated by such contracts. Cash flow and cash requirement risks are closely tied to, and are dependent upon, our ability to attract significant long-term production contracts.  In the short term, we must continue to obtain funding to operate and expand our operations so that we can deliver our unique Bend Sensor® and Bend Sensor® related technologies and products to the market.  Management believes that even though we have made positive strides forward with our business plan, it is likely that significant progress may not occur for the next six to nine months, primarily due to the time it takes for negotiating such contracts.  Accordingly, we cannot guarantee that we will realize significant revenues or that we will become profitable over the next six to nine months.


In May 2017 the Company also announced that initial clinical tests for Haemoband have completed.  Haemoband is expected to incorporate the Bend Sensor® in multiple product and device types that will launch beginning in late 2017.  We anticipate that production orders for these new products will begin in late  2017 and are expected to significantly increase in 2018.


The product launch of a wearable shoe application is expected to take place in Europe in the second half of 2017. The second half of this year will also see the product launch in North America of a medical orthotics shoe product. Between these two products, sensor volume is estimated to be 175,000.


LIQUIDITY AND CAPITAL RESOURCES


Currently our revenue is primarily from design contract, testing and limited production services for prototypes and samples, and is not to a level to support our operations.  For the past twelve months we have relied on the proceeds of convertible loans from existing shareholders and private placements of our common stock.  However, we believe, based upon current orders and projected orders over the next twelve months, that we could be producing sensors under long-term contracts that will help support our existing operations and potential future growth.  Management recognizes such contracts usually go through a long negotiation process and there can be no guarantee that we will be successful in our negotiations or that such contracts will be sufficient to support our current operations in the near future.



13





Management believes that our current cash burn rate is approximately $75,000 per month and the proceeds from the convertible notes and our manufacturing, engineering and design fees will not totally fund our anticipated growth in operations. We will therefore need to raise additional financing. We believe that this additional financing will provide the needed capital to extend operations to the development and production of our growing product offerings and growing manufacturing opportunities. However, we may not be able to obtain financing, or the sources of financing, if any, may not continue to be available, and if available, they may be on terms unfavorable to us.


We also expect that in the short term we may have to continue to issue common stock to pay for services and agreements rather than use our limited cash resources.  Any issuance of common stock will likely be pursuant to exemptions provided by federal and state securities laws. The purchasers and manner of issuance will be determined according to our financial needs and the available exemptions.  We also note that if we issue more shares of our common stock our shareholders may experience dilution in the value per share of their common stock.  


As we enter into production and development agreements, we must ensure that those agreements provide adequate funding for any pre-production research and manufacturing costs. As we are successful in establishing agreements with adequate initial funding, management believes that our operations for the long term will be funded by revenues, licensing fees and/or royalties related to these agreements. However, we have formalized only a few agreements during the past four years and there can be no assurance that the agreements will generate sufficient revenues or be profitable in the future or that a desired technological application will be successful enough to produce the volumes and profits necessary to fund our operations.  


FINANCIAL OBLIGATIONS AND CONTINGENT LIABILITIES


Our principal commitments at June 30, 2017 consisted of our operating lease of $9,600 per month, and total liabilities of $2,675,642, which includes $1,381,978 of convertible notes payable, net of debt discounts.  Accrued liabilities at June 30, 2017, were $975,449 and were related to payroll, payroll tax liabilities, accrued professional expenses, accrued insurance expense, accrued interest expense on notes and accrued paid time off.  


During the six months ending June 30, 2017, the Company has raised an additional $200,000 in operating capital through the issuance of short-term notes.  The notes have an annual interest rate of 8 to 10% and a default rate of 12 to 15% annually. The notes, which total $1,364,000 (excluding debt discounts), are secured by the Company’s business equipment and have a conversion feature for restricted common shares at $0.05 to $0.07 per share.


The Company has a major customer which is an American-based, Fortune 500, global toy manufacturing company which it supplies through its global assembly partner who represents a significant portion of revenue and accounts receivable.  During the six months ended June 30, 2017, the customer represented 45% of sales and represents 11% of accounts receivable at June 30, 2017.  The Company has a strong ongoing relationship with this customer with scheduled deliveries extending through the year and does not believe this concentration poses a significant risk, as apportion of the control for their products is based on the Company’s technologies


OFF-BALANCE SHEET ARRANGEMENTS


Other than our current operating lease, we have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.


CRITICAL ACCOUNTING ESTIMATES


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates of particular significance in our financial statements include goodwill and the annual tests for impairment of goodwill and long-lived assets and valuing stock option compensation.  


The Company's goodwill represents the excess of its reorganization value over the fair value of the net assets upon emergence from bankruptcy. Goodwill is not amortized, therefore we test our goodwill for impairment annually or when a triggering event occur using a fair value approach. A fair value based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its nets assets. The test requires various judgments and estimates. During 2016 and for the six months ending June 30, 2017, the Company recorded



14




no impairment charge to reduce the carrying value of the goodwill to its estimated fair value. As part of the impairment testing performed at December 31, 2016, the Company considered factors such as the global market volatility, variables in the economy, and the overall uncertainty in the markets which has resulted in a decline in the market price of the Company's stock price and market capitalization for a sustained period, as indicators for potential goodwill impairment.


We test long-lived assets for impairment annually or when a triggering event occurs. Impairment is indicated if undiscounted cash flows are less than the carrying value of the assets. The amount of impairment is measured using a discounted-cash-flows model considering future revenues, operating costs and risk-adjusted discount rate and other factors. The analysis compares the present value of projected net cash flows for the remaining current year and next two years against the carrying value of the long-lived assets. If the carrying values of the long-lived assets exceed the present value of the discounted projected revenues an impairment expense would be recognized in the period and the carrying value of the assets would be adjusted accordingly. Impairment tests are conducted on an annual basis and, should they indicate a carrying value in excess of fair value, a charge may be required.


Financial accounting standards require that recognition of the cost of employee services received in exchange for stock options and awards of equity instruments be based on the grant-date fair value of such options and awards and is recognized as an expense in operations over the period they vest. The fair value of the options we have granted is estimated at the date of grant using the Black-Scholes American option-pricing model. Option pricing models require the input of highly sensitive assumptions, including expected stock volatility. Also, our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimate.  Management believes the best input assumptions available were used to value the options and that the resulting option values are reasonable. For the six month periods ended June 30, 2017 and 2016 we recognized $9,890 and $16,802, respectively, of stock-based compensation expense for our stock options and there is no additional unrecognized compensation cost related to employee stock options at the current time.


RESULTS OF OPERATIONS


The following discussions are based on the consolidated operations of Flexpoint Sensor Systems, Inc. and should be read in conjunction with our unaudited financial statements for the three and six months ended June 30, 2017 and 2016, included in Part I, Item 1, above, and the audited financial statements included in the Company’s annual report on Form 10-K for the years ended December 31, 2016 and 2015.


THREE MONTH PERIOD ENDED JUNE 30, 2017:


SUMMARY OF OPERATING RESULTS

 


Three month period ended

 

June 30, 2017

 

June 30, 2016

Design, contract and testing revenue

$            154,636

 

$            93,039

Total operating costs and expenses

317,883

 

278,728

Net other income (expense)

(30,227)

 

(228,792)

Net loss

(193,474)

 

(414,4815

Basic and diluted loss per common share

(0.00)

 

(0.01)


For the three months ending June 30, 2017 revenue was $154,636, a $61,597 increase when compared to the same period in 2016. The majority of the revenue for this period came from production of products. The Company continues to concentrate its marketing resources on a limited number of customers that have the greatest potential to generate the most short-term revenue while still building relationships with our larger customers. Management believes this approach has the highest potential to bring long-term commercially viable products to market and will provide sustainable cash flow to fund the Company's operations in the future. Currently, overall revenues are not sufficient to sustain our operations.  Management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering. However, until a long-term production contract is in place there is no guarantee that our current customer base will order in sufficient volumes to sustain our operations. Therefore, management continues to work with larger companies and industries and is hopeful that in the near future we will sign a long-term licensing or manufacturing contract.


We received revenue from repeat orders from our existing customers, design contract, and development engineering. Revenue from the sale of a product is recorded at the time of shipment to the customer.  Revenue from research and



15




development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contract are met and then the sale is recognized as licensing royalty revenue over the remaining term of the contract.


Of the $317,883 and $278,728 total operating costs and expense for the three months ending June 30, 2017 and 2016, respectively, $85,143 and $79,281 were for direct research and development cost, respectively. For the three months ended June 30, 2017, total operating expenses increased by $39,155 when compared to the same period in 2016, due primarily to increased costs to meet higher product production and sales levels.  


Other expense for the three month period ended June 30, 2017 was $30,227, a $198,565 decrease compared to the same period in 2016.  The decrease is attributable primarily to the difference in beneficial conversion charges on the convertible notes in 2017 versus 2016.   


A net loss of $193,474 was realized for the three months ended June 30, 2017.  A net loss of $414,481 was realized for the three month period ended June 30, 2016.


SIX MONTH PERIOD ENDED JUNE 30, 2017:


SUMMARY OF OPERATING RESULTS

 


Six month period ended

 

June 30, 2017

 

June 30, 2016

Design, contract and testing revenue

$            215,701

 

$            128,205

Total operating costs and expenses

584,534

 

561,293

Net other income (expense)

(116,138)

 

(450,768)

Net loss

(484,971)

 

(883,856)

Basic and diluted loss per common share

(0.01)

 

(0.01)


For the six months ending June 30, 2017 revenue was $215,701, a $87,496 increase when compared to the same period in 2016. The majority of the revenue for this period came from production products.  Management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering.


Of the $584,534 and $561,293 total operating costs and expense for the six months ending June 30, 2017 and 2016, respectively, $164,509 and $159,340 were for direct research and development cost, respectively. For the six months ended June 30, 2017, total operating expenses increased by $23,241 when compared to the same period in 2016, due primarily to increases in personnel and supplies required to meet higher levels of production.  


Other expense for the six month period ended June 30, 2017 was $116,138, a $334,630 decrease compared to the same period in 2016.  The decrease is attributable primarily to the difference in beneficial conversion charges on the convertible notes in 2017 versus 2016.   


A net loss of $484,971 was realized for the six months ended June 30, 2017.  A net loss of $883,856 was realized for the six month period ended June 30, 2016.




16





The chart below represents a summary of our condensed consolidated balance sheets at June 30, 2017 and December 31, 2016.


SUMMARY OF BALANCE SHEET INFORMATION

 

 

 

 

 

June 30, 2017

 

December 31, 2016

Cash and cash equivalents

$                 686 

 

$                     - 

Total current assets

129,303 

 

93,847 

Total assets

            5,108,301

 

            5,104,495

Total liabilities

              2,675,642

 

            2,196,755

Deficit accumulated

         (26,707,782)

 

         (26,222,811)

Total stockholder’s equity

 $       2,432,654

 

 $       2,907,740


Cash and cash equivalents increased by $686 at June 30, 2017 compared to December 31, 2016. The increase in cash is due to the timing of payment of expenses, collection of accounts receivable and proceeds from borrowings. Our non-current assets decreased at June 30, 2017 due to the amortization of long-lived assets.


Total liabilities increased by $478,887 at June 30, 2017.  The increase was due primarily to the funding of operations through the issuance of convertible notes payable, the accrued interest related to those notes, accruals for investor relations and insurance expenses and an increase in the derivative liabilities.


INFLATION


We do not expect the impact of inflation on our operations to be significant for the next twelve months.



ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Not applicable to smaller reporting companies.



ITEM 4.  CONTROLS AND PROCEDURES


(a)

Disclosure Controls and Procedures


As of the end of the period covered by this quarterly report we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of our disclosure controls and procedures.  Our controls and procedures are designed to allow information required to be disclosed in our reports to be recorded, processed, summarized and reported within the specified periods, and accumulated and communicated to management to allow for timely decisions regarding required disclosure of material information.  Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives.  Based upon the evaluation, our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective at that reasonable assurance level as of the end of the period June 30, 2017.  


The material weaknesses relate to the limited number of persons responsible for the recording and reporting of financial information, the lack of separation of financial reporting duties, and the limited size of our management team in general. We are in the process of evaluating methods of improving our internal control over financial reporting, including the possible addition of financial reporting staff and the increased separation of financial reporting responsibility, and intend to implement such steps as are necessary and possible to correct these material weaknesses


(b)

Changes in Internal Control over Financial Reporting


There have been no changes in internal control over financial reporting during the quarter ended June 30, 2017 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.




17





PART II - OTHER INFORMATION



ITEM 1. LEGAL PROCEEDINGS


None.



ITEM 1A.  RISK FACTORS


We have a history of losses and may never become profitable.


We are unable to fund our day-to-day operations from revenues and the lack of revenues for continued growth may cause us to delay our business development.  For the six months ending June 30, 2017, we had negative cash flows from operating activities of $218,381. We will require additional financing to fund our short-term cash needs and we may be required to rely on debt financing, loans from related parties, and private placements of our common stock for that additional funding. Such funding sources may not be available or the terms of such funding sources may not be acceptable to the company. If the Company is unable to find such funding it could have a material adverse effect on our ability to continue as a going concern.


We may not have adequate resources to successfully manage anticipated growth.


We may not be equipped to successfully manage any possible future periods of rapid growth or expansion, which could be expected to place a significant strain on our managerial, operating, financial and other resources.  Our future performance will depend, in part, on our ability to manage growth effectively, which will require us to:


·

improve existing, and implement new, financial controls and systems, management information systems, operating, administrative, financial and accounting systems and controls,

·

maintain close coordination between engineering, programming, accounting, finance, marketing, sales and operations, and

·

attract and retain additional qualified technical and marketing personnel.


There is intense competition for management, technical and marketing personnel in our business.  The loss of the services of any of our key employees or our failure to attract and retain additional key employees could have a material adverse effect on our ability to continue as a going concern.


Our success is dependent on our intellectual property rights which are difficult to protect.


Our future success depends on our ability to protect our intellectual property. We use a combination of patents and other intellectual property arrangements to protect our intellectual property. There can be no assurance that the protection provided by our patents will be broad enough to prevent competitors from introducing similar products or that our patents, if challenged, will be upheld by courts of any jurisdiction. Patent infringement litigation, either to enforce patents or defend ourselves from infringement suits, will be expensive and could divert our resources from other planned uses. Patent applications filed in foreign countries and patents in these countries are subject to laws and procedures that differ from those in the U.S. and may not be as favorable to us. We also attempt to protect our confidential information through the use of confidentiality agreements and by limiting access to our facilities. There can be no assurance that our program of patents, confidentiality agreements and restricted access to our facilities will be sufficient to protect our confidential information and intellectual properties from our competitors.


Research and development may result in problems which may become insurmountable to full implementation of production.


Customers request that we create prototypes and perform pre-production research and development. As a result, we are exposed to the risk that we may find problems in our designs that are insurmountable to fulfill production.  In that event, we would be unable to recover the costs of the pre-production research and development. However, we are currently unaware of any insurmountable problems with ongoing research and development that may prevent further development of an application.





18




Because we are significantly smaller than the majority of our competitors, we may lack the financial resources needed to capture increased market share.


The market for sensor devices is extremely competitive, and we expect that competition will intensify in the future. There can be no assurance that we will be able to compete successfully against current or future competitors or that competitive pressures we face will not materially adversely affect our business, operating results or financial condition. Our primary competitors in the VR/AR market are Interlink Electronics and manufacturers of accelerometers and IMU’s, (Inertial Measurement Units).  Our Primary competitors in the air bag market are International Electronics and Engineering, Siemens, Robert Bosch GmbH, Denso, Inc., Breed Technologies, TRW Automotive, Delphi Corporation, Autoliv Inc., Takata and Temic. We believe that none of our competitors have a product that is superior to our Bend Sensor® technology at this time. However, many of our competitors and potential competitors have substantially greater financial, technical and marketing resources, larger customer bases, longer operating histories, greater name recognition and more established relationships than we do. These competitors may be able to undertake more extensive marketing campaigns, adopt more aggressive pricing policies and devote substantially more resources to developing new products and markets than we can.



ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS


The Company has not issued any securities since the year ended December 31, 2016.



ITEM 3.  DEFAULTS UPON SENIOR SECURITIES


None.



ITEM 4.  MINE SAFETY DISCLOSURES


Not applicable.



ITEM 5.  OTHER INFORMATION


None.





[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]



19




ITEM 6. EXHIBITS


Part I Exhibits


No.

Description

31.1

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley



Part II Exhibits


No.

Description

3.1

Certificate of Incorporation of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.1 for Form 10-QSB, filed August 4, 2006)

3.2

Bylaws of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.4 of Form 10-QSB, filed May 3, 2004)

10.1

Addendum to Lease Agreement between Flexpoint Sensor and Handstands, dated January 1, 2015.  (Incorporated by reference to exhibit 10.3 of Form 10-K, filed April 14, 2016)

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Label Linkbase Document

101.PRE

XBRL Taxonomy Presentation Linkbase Document      





20




SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, who is duly authorized.


FLEXPOINT SENSOR SYSTEMS, INC.


Date:   August 14, 2017


/s/ Clark M. Mower

Clark M. Mower

President, Chief Executive Officer and Director,

Principal Financial Officer



21



EX-31 2 ex311.htm 302 CERTIFICATION OF CLARK M. MOWER, CEO Exhibit 31

Exhibit 31.1


CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


     I, Clark M. Mower certify that:


     1.   I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;


     2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a      material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


     3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


    4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:  


a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;  


b)

designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;


c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


     5.   The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);


a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




Dated:  August 14, 2017

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer



EX-31 3 ex312.htm 302 CERTIFICATION OF CLARK M. MOWER, CFO Converted by EDGARwiz

Exhibit 31.2


CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


     I, Clark M. Mower, certify that:


    1.   I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;


     2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


     3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


    4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:  


a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;  


b)

designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;


c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  


d)

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


     5.   The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);


a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




Dated:  August 14, 2017

 

/s/ Clark M. Mower

Clark M. Mower

Principal Financial Officer



EX-32 4 ex32.htm SECTION 1350 CERTIFICATION Converted by EDGARwiz

    Exhibit 32



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc. (the “Company”) for the period ending June 30, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Clark M. Mower, Chief Executive Officer and Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


     (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


     (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




Dated:  August 14, 2017

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer

Principal Financial Officer







EX-101.INS 5 flxt-20170630.xml XBRL INSTANCE DOCUMENT 0000925660 2017-01-01 2017-06-30 0000925660 2015-12-31 0000925660 us-gaap:MinimumMember 2017-01-01 2017-06-30 0000925660 us-gaap:MaximumMember 2017-01-01 2017-06-30 0000925660 us-gaap:SalesRevenueNetMember flxt:CustomerOneMember 2017-01-01 2017-06-30 0000925660 us-gaap:AccountsReceivableMember flxt:CustomerOneMember 2017-01-01 2017-06-30 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:DirectorMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:EmployeeMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeOneMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeTwoMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeFourMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeThreeMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member 2017-01-01 2017-06-30 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2005-08-25 2016-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2005-08-25 2016-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember 2005-08-25 2016-12-31 0000925660 flxt:StockIncentivePlan2005Member 2017-06-30 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2015-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2015-12-31 0000925660 us-gaap:ChiefExecutiveOfficerMember 2017-06-30 0000925660 us-gaap:ChiefExecutiveOfficerMember 2016-12-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember 2017-06-30 0000925660 2017-06-30 0000925660 2016-12-31 0000925660 flxt:DerivativeClassificationMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0000925660 flxt:DerivativeClassificationMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0000925660 flxt:DerivativeClassificationMember 2017-01-01 2017-06-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-12-31 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-12-31 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:TwoThousandSixMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:JanuarySixMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:JanuaryThirtyOneMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:MarchSevenMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:AprilTwentyEightMember 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2016-12-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-07-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-09-30 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-07-02 2016-07-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-09-01 2016-09-30 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-09-22 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-06-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2015-12-31 0000925660 2016-01-01 2016-06-30 0000925660 2016-04-01 2016-06-30 0000925660 2017-04-01 2017-06-30 0000925660 2016-06-30 0000925660 2017-08-14 0000925660 flxt:NewConvertibleNotesPayableMember 2017-06-30 0000925660 flxt:NewConvertibleNotesPayableMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:JuneTwoMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:JulyThirteenMember 2017-01-01 2017-06-30 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:DirectorMember 2011-08-08 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:DirectorMember 2011-08-07 2011-08-08 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:SubsequentEventMember 2017-07-01 2017-07-13 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:SubsequentEventMember 2017-07-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure FLEXPOINT SENSOR SYSTEMS INC 0000925660 10-Q 2017-06-30 false --12-31 Smaller Reporting Company Q2 2017 22706 686 2772 119249 84499 9368 9348 129303 93847 6550 6550 4896917 4896917 5108301 5104495 186279 172602 15594 1420 15594 1420 975449 741778 1324660 1184660 35046 20000 2675642 2196755 78363 78363 29062078 29052188 -26707782 -26222811 2432659 2907740 5108301 5104495 102140 102140 587886 586787 906571 876037 25928 0.001 0.001 1000000 1000000 0.001 0.001 100000000 100000000 78363464 78363464 78363464 78363464 215701 128205 93039 154636 30533 46087 22346 12110 34641 2510 1166 30892 354851 353356 175935 189738 164509 159340 79281 85143 584534 561293 278728 317883 165340 454598 230707 63730 23 3830 1915 11 -116138 -450768 -228792 -30227 -0.01 -0.01 -0.01 -0.00 78363464 71627114 71627114 78363464 34750 85527 20 -2625 13674 7943 214604 186892 3807 -3807 180000 160000 40000 40000 40000 250000 40000 40000 40000 219667 285870 686 -19934 P5Y P15Y 27986602 21648704 0.45 0.11 -484971 -883856 -414481 -193474 -218381 -301997 20000 300000 20000 10000 300000 40000 300000 2016-07-01 2016-07-01 2016-09-22 2017-05-25 2016-12-31 2016-12-31 2016-12-31 2018-07-31 2015-12-31 0.08 0.10 0.10 0.08 0.10 0.10 0.10 0.10 2017-12-31 8950 9300 9600 P10Y 2500000 2185000 1960000 225000 640000 500000 50000 995000 3096000 0.14 0.15 0.25 0.20 0.14 2.07 P2Y4M P3Y P10Y 2.07 0.14 P10Y P3Y8M12D 0.0493 0.0160 0.00 4.24 2.00 2.07 0.16 2185000 2185000 9704 10823 9890 16802 1000 25928 56750 1286 10052 9890 16802 0.01 22272 20000 P8Y7M28D P8Y1M27D 65824 96358 14174 516 0.07 0.07 0.07 0.07 0.08 0.07 0.07 116342 76295 49179 33492 19067 35870 63298 116342 0.00 1.1457 1.2815 0.0076 0.0114 P6M P1Y29D 76295 116342 40892 89226 35403 -49179 116342 116342 116342 116342 63298 0.17 0.16 P8Y1M27D 3246 405521 78363464 -368833 -433088 -185689 -163247 1120 20000 1836667 0.17 <div style="width: 624px"><p style="margin: 0px"><b>NOTE 1<i><font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="margin: 0px; line-height: 12pt"><br /></p> <p style="margin: 0px"><b><i>Condensed Consolidated Interim Financial Statements <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the <font style="font-family: Arial Unicode MS,Times New Roman">&#147;</font>Company<font style="font-family: Arial Unicode MS,Times New Roman">&#148;</font>). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report.&#160;In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Nature of Operations</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through June 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Use of Estimates <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. &#160;Actual results could differ from those estimates.</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Cash and Cash Equivalents <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. </p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px"><b><i>Fair Value Measurements</i> -&#160;</b>The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s own credit risk.</p> <p style="margin: 0px">&#160;</p> <p style="margin: 0px">Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</p> <p style="margin: 0px; text-indent: 48px">&#160;</p> <p style="padding-left: 48px; margin: 0px">Level 1: Quoted market prices in active markets for identical assets or liabilities.</p> <p style="margin: 0px">&#160;</p> <p style="padding-left: 48px; margin: 0px">Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="margin: 0px">&#160;</p> <p style="padding-left: 48px; margin: 0px">Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.</p> <p style="text-align: justify; margin: 0px">&#160;</p> <p style="margin: 0px">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.</p> <p style="margin: 0px; text-indent: 48px">&#160;</p> <p style="margin: 0px">The carrying value of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.</p> <p style="margin: 0px; text-indent: 48px">&#160;</p> <p style="margin: 0px">The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Accounts Receivable <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. &#160;The balance in the allowance account was $102,140 and $102,140 in the periods ended June 30, 2017 and December 31, 2016, respectively. &#160;</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Property and Equipment</i> <i><font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font></i></b> Property and equipment are stated at cost. &#160;Additions and major improvements are capitalized while maintenance and repairs are charged to operations. &#160;Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px"><b><i>Valuation of Long-lived Assets</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> The carrying values of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the period ended June 30, 2017 and during the period ended June 30, 2016. &#160;Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.</p> <p style="margin: 0px; line-height: 12pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Intangible Assets</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. &#160;Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years. &#160;An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. &#160;Under similar analysis there was no impairment charge taken during the period ended June 30, 2017 and during the period ended June 30, 2016. </p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Research and Development</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.</p> <p style="margin: 0px; line-height: 12pt"><br /></p> <p style="margin: 0px"><b><i>Goodwill</i> </b><font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Goodwill represents the excess of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or <font style="font-family: Arial Unicode MS,Times New Roman">&#147;</font>ASC<font style="font-family: Arial Unicode MS,Times New Roman">&#148;</font>) 350-20 Intangibles <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value. </p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 9.4pt"><b><i>Revenue Recognition <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. &#160;Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. &#160;Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. &#160;The Company does not provide extended warranties or guarantees on its products.</p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><b><i>Stock-Based Compensation</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. &#160; All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended June 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $9,890 and $16,802, respectively.</p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px"><b><i>Basic and Diluted Loss Per Share <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font></i></b> Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. &#160;Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At June 30, 2017 and June 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 27,986,602 and 21,648,704, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share. </p> <p style="margin: 0px"><br /></p> <p style="margin: 0px"><b><i>Concentrations and Credit Risk - </i></b>The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable. &#160;During the six month period ended June 30, 2017, a customer who manufacturers toys represented 45% of sales and represented 11% of accounts receivable. &#160;The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s technologies. &#160;</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px"><b><i>Income Taxes - </i></b>The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. &#160;Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. &#160;Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized</p> <p style="margin: 0px"><br /></p> <p style="text-align: justify; margin: 0px"><b><i>Recent Accounting Pronouncements </i></b>- In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-09, "Stock Compensation - Scope of Modification Accounting". This ASU requires all modifications to be accounted for as a modification unless the fair value, vesting conditions and classification of the award as equity or liability are the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective for fiscal years beginning after December 15, 2017 and for interim periods therein. The Company does not believe this ASU will have a material impact on its consolidated financial position, results of operation or cash flows.</p> <p style="text-align: justify; margin: 0px"><br /></p> <p style="text-align: justify; margin: 0px">The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. &#160;Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </p></div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b>NOTE 3 <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> DERIVATIVE INSTRUMENTS</b></p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="text-align: justify; margin: 0px">The derivative liability as of June 30, 2017, in the amount of $116,342 has a Level 3 fair value classification. The following table provides a summary of changes in fair value of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s Level 3 financial liabilities as of June 30, 2017 and December 31, 2016:</p> <p style="text-align: justify; margin: 0px">&#160;</p> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td colspan="2" style="width: 139px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Total</b></p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Balance, December 31, 2015</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Recognition of derivative liabilities upon initial valuation</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">40,892</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Change in fair value of derivative liabilities</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">35,403</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Conversions of derivative liabilities into equity instruments</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Balance, December 31, 2016</p></td> <td style="width: 36px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">76,295</p></td> <td style="width: 1px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Recognition of derivative liabilities upon initial valuation</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">89,226</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Change in fair value of derivative liabilities</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">(49,179)</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Conversions of derivative liabilities into equity instruments</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Balance, June 30, 2017</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 1px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 137px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">116,342</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> </table> <p style="text-align: justify; margin: 0px">&#160;</p> <p style="margin: 0px">During the year ended 2016 and the period ended June 30, 2017, the Company issued convertible promissory notes which are convertible into common stock. Due to the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle all convertible instruments. &#160;The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.</p> <p style="margin: 0px">&#160;</p> <p style="margin: 0px">At June 30, 2017, the Company marked to market the fair value of the derivatives and determined a fair value of $116,342. The Company recorded a gain from change in fair value of derivatives of $49,179 for the six month period ended June 30, 2017. During the six months ended June 30, 2017, the Company recorded additional interest expense of $63,298 and debt discounts of $25,928 in connection with the recognition of derivative liabilities. The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 114.57% to 128.15%, (3) weighted average risk-free interest rate of 0.76% to 1.14% (4) expected life of 0.50 to 1.08 years, and (5) the quoted market price of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s common stock at each valuation date.</p> <p style="text-align: justify; margin: 0px; text-indent: 48px">&#160;</p> <p style="text-align: justify; margin: 0px">In accordance ASC 840-15-25, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.</p> <p style="text-align: justify; margin: 0px; text-indent: 48px">&#160;&#160;</p> <p style="text-align: justify; margin: 0px">As of June 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:</p> <p style="text-align: justify; margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" align="center" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 275px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 13px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 69px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Level 1</b></p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 68px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Level 2</b></p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 68px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Level 3</b></p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 68px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Total</b></p></td></tr> <tr> <td style="width: 275px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Derivative Liabilities</p></td> <td style="width: 13px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">116,342</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">116,342</p></td></tr> <tr> <td style="width: 275px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Total</p></td> <td style="width: 13px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">116,342</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">116,342</p></td></tr> </table> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt"><i><u>Convertible Notes Payable</u></i></p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt">The Company entered into a new promissory note for up to $300,000 from a third party on May 25, 2017. &#160;The note has an annual interest rate of 10% and is secured by the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s equipment. &#160;The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of July 31, 2018. &#160;The Company drew $40,000 against that note on June 2, 2017 and $40,000 on July 13, 2017. &#160; </p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10pt">The Company entered into a convertible promissory note for up to $300,000 from a third party on July 1, 2016. &#160;The note has an annual interest rate of 10% and is secured by the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s equipment. &#160;The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016. &#160;The Company drew $160,000 against that note during 2016 and $40,000 on January 6, 2017; $40,000 on January 31, 2017 $40,000 on March 7, 2017 and the balance of $20,000 on April 28, 2017.</p> <p style="margin: 0px; line-height: 10pt"><br /></p> <p style="margin: 0px; line-height: 9.4pt">On August 8, 2011, the Company entered into a convertible note payable with a former Company Director for $40,000. This note was due on December 31, 2015, bears an annual interest rate of 10% annual interest and is secured by business equipment.</p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px; line-height: 9.4pt"><i><u>Convertible Note Payable Related Party</u></i></p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px">On April 17, 2017 the Company issued a note for $20,000 to an officer of the Company. &#160;The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2017. &#160;The note is secured by all of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s business equipment.</p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px">On July 1, 2016 and September 22, 2016, the Company issued two promissory notes for $10,000 each to an officer of the Company. &#160;The notes bear interest at the rate of 10%, have a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016. &#160;Since the fair value of the common stock at the date of the July 1, 2016 advance was $0.07, no BCF was recorded.</p></div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b>NOTE 4 <i><font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font></i> STOCK OPTION PLANS</b></p> <p style="margin-bottom: 5px; margin-top: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 9.4pt">On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated. &#160;This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent. &#160;The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares. <b>&#160;</b>The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock. </p> <p style="margin: 0px; line-height: 9.4pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt">On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s common stock. &#160;Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees. &#160;Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share. &#160;Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively. &#160;We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt">Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options. &#160;Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share. &#160;The options vest over three years and expire 10 years from the date of grant. &#160;The Company used the following assumptions in estimating the fair value of the options granted:</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin-bottom: -2px; font: 12pt/10.65pt Symbol; width: 99px; float: left; margin-top: 0px; text-indent: 75px">&#183;</p> <p style="padding-left: 99px; margin: 0px; line-height: 10.65pt; text-indent: -2px">Market value at the time of issuance <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Range of $0.14 to 2.07</p> <p style="margin-bottom: -2px; font: 12pt/10.65pt Symbol; width: 99px; float: left; clear: left; margin-top: 0px; text-indent: 75px">&#183;</p> <p style="padding-left: 99px; margin: 0px; line-height: 10.65pt; text-indent: -2px">Expected term <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Range of 3.7 years to 10.0 years</p> <p style="margin-bottom: -2px; font: 12pt/10.65pt Symbol; width: 99px; float: left; clear: left; margin-top: 0px; text-indent: 75px">&#183;</p> <p style="padding-left: 99px; margin: 0px; line-height: 10.65pt; text-indent: -2px">Risk-free interest rate <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Range of 1.60% to 4.93%</p> <p style="margin-bottom: -2px; font: 12pt/10.65pt Symbol; width: 99px; float: left; clear: left; margin-top: 0px; text-indent: 75px">&#183;</p> <p style="padding-left: 99px; margin: 0px; line-height: 10.65pt; text-indent: -2px">Dividend yield <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> 0%</p> <p style="margin-bottom: -2px; font: 12pt/10.65pt Symbol; width: 99px; float: left; clear: left; margin-top: 0px; text-indent: 75px">&#183;</p> <p style="padding-left: 99px; margin: 0px; line-height: 10.65pt; text-indent: -2px">Expected volatility <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> 200% to 424%</p> <p style="margin-bottom: -2px; font: 12pt/10.65pt Symbol; width: 99px; float: left; clear: left; margin-top: 0px; text-indent: 75px">&#183;</p> <p style="padding-left: 99px; margin: 0px; line-height: 10.65pt; text-indent: -2px">Weighted-average fair value - $0.16 to $2.07</p> <p style="clear: left; margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt">During the six months ended June 30, 2017, the Company recognized a total of $9,890 of stock-based compensation expense, leaving $10,052 in unrecognized expense as of June 30, 2017. During the six months ended June 30, 2016, the Company recognized $16,802 in stock-based compensation expense. There were 2,185,000 and 2,185,000 employee stock options outstanding at June 30, 2017 and December 31, 2016, respectively. &#160;</p> <p style="margin: 0px; line-height: 10.65pt"><br /></p> <p style="margin: 0px; line-height: 10.65pt">A summary of all employee options outstanding and exercisable under the plan as of June 30, 2017, and changes during the three months then ended is set forth below:</p> <p style="margin: 0px; line-height: 10.65pt"><br />&#160;</p> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 237px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Options</b></p></td> <td style="width: 90px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Shares</b></p></td> <td style="width: 114px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Weighted Average Exercise Price</b></p></td> <td style="width: 83px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Weighted Average Remaining Contractual &#160;Life (Years)</b></p></td> <td style="width: 85px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Aggregate Intrinsic Value</b></p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><br /></p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Outstanding at the beginning of period </p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,185,000 </p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.16 </p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.66 </p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;&#160;&#160;Granted</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">--&#160;&#160;&#160;</p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">--</p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;&#160;&#160;Expired</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;--</p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</b></p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;&#160;&#160;Forfeited</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">-- &#160;&#160;</p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">--</p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Outstanding at the end of Period</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,185,000 </p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.17 </p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.16 </p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Exercisable at the end of Period</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">1,836,667 </p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.17 </p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.16 </p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;--&#160;&#160;&#160; </p></td></tr> </table> </div> <div style="width: 624px"><p style="margin: 0px"><b>NOTE 4 <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> CAPITAL STOCK</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 10.65pt">Preferred Stock <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. &#160;At June 30, 2017 and December 31, 2016, there were no shares of preferred stock issued or outstanding.</p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 10.65pt">Common Stock <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized. &#160;No shares of stock were issued during the six months ended June 30, 2017. &#160;</p></div> <div style="width: 624px"><p style="margin: 0px"><b>NOTE 5 - COMMITMENTS AND CONTINGENCIES</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 10.65pt">The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017. &#160;Either party may terminate the lease upon 90 day written notice. &#160;Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), $9,300 per month in 2016 and $9,600 per month in 2017. </p></div> <div style="width: 624px"><p style="margin: 0px"><b>NOTE 6 <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> RELATED PARTY TRANSACTIONS</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px; line-height: 12pt">At June 30, 2017 and December 31, 2016, the Company had accounts payable of $15,594 and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.</p></div> <div style="width: 624px"><p style="margin: 0px"><b>NOTE 7- SUBSEQUENT EVENTS</b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px">On July 13, 2017 the Company drew $40,000 against a convertible promissory note for up to $300,000 from a third party, the proceeds of which will be used to fund operating expenses. The note has an annual interest rate of 10% and is secured by the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s equipment. The note has a conversion feature for restricted common shares at $.07 per share. &#160;</p> </div> <div style="width: 624px"><p style="margin: 0px"><b><i>Fair Value Measurements</i> -&#160;</b>The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s own credit risk.</p> <p style="margin: 0px">&#160;</p> <p style="margin: 0px">Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</p> <p style="margin: 0px; text-indent: 48px">&#160;</p> <p style="padding-left: 48px; margin: 0px">Level 1: Quoted market prices in active markets for identical assets or liabilities.</p> <p style="margin: 0px">&#160;</p> <p style="padding-left: 48px; margin: 0px">Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="margin: 0px">&#160;</p> <p style="padding-left: 48px; margin: 0px">Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.</p> <p style="text-align: justify; margin: 0px">&#160;</p> <p style="margin: 0px">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.</p> <p style="margin: 0px; text-indent: 48px">&#160;</p> <p style="margin: 0px">The carrying value of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.</p> <p style="margin: 0px; text-indent: 48px">&#160;</p> <p style="margin: 0px">The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.</p></div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Property and Equipment</i> <i><font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font></i></b> Property and equipment are stated at cost. &#160;Additions and major improvements are capitalized while maintenance and repairs are charged to operations. &#160;Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.</p> </div> <div style="width: 624px"><p style="margin: 0px"><b><i>Valuation of Long-lived Assets</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> The carrying values of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the period ended June 30, 2017 and during the period ended June 30, 2016. &#160;Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.</p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Intangible Assets</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. &#160;Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years. &#160;An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. &#160;Under similar analysis there was no impairment charge taken during the period ended June 30, 2017 and during the period ended June 30, 2016. </p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Research and Development</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.</p> </div> <div style="width: 624px"><p style="margin: 0px"><b><i>Goodwill</i> </b><font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Goodwill represents the excess of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or <font style="font-family: Arial Unicode MS,Times New Roman">&#147;</font>ASC<font style="font-family: Arial Unicode MS,Times New Roman">&#148;</font>) 350-20 Intangibles <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value. </p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 9.4pt"><b><i>Revenue Recognition <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. &#160;Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. &#160;Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. &#160;The Company does not provide extended warranties or guarantees on its products.</p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Stock-Based Compensation</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. &#160; All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended June 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $9,890 and $16,802, respectively.</p> </div> <div style="width: 624px"><p style="margin: 0px"><b><i>Basic and Diluted Loss Per Share <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font></i></b> Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. &#160;Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At June 30, 2017 and June 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 27,986,602 and 21,648,704, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share. </p> </div> <div style="width: 624px"><p style="margin: 0px"><b><i>Concentrations and Credit Risk - </i></b>The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable. &#160;During the six month period ended June 30, 2017, a customer who manufacturers toys represented 45% of sales and represented 11% of accounts receivable. &#160;The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s technologies. &#160;</p> </div> <div style="width: 624px"> <p style="margin: 0px"><b><i>Income Taxes - </i></b>The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. &#160;Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. &#160;Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized</p> </div> <div style="width: 624px"><p style="margin: 0px; text-align: justify"><b><i>Recent Accounting Pronouncements </i></b>- In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-09, "Stock Compensation - Scope of Modification Accounting". This ASU requires all modifications to be accounted for as a modification unless the fair value, vesting conditions and classification of the award as equity or liability are the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective for fiscal years beginning after December 15, 2017 and for interim periods therein. The Company does not believe this ASU will have a material impact on its consolidated financial position, results of operation or cash flows.</p> <p style="text-align: justify; margin: 0px"><br /></p> <p style="text-align: justify; margin: 0px">The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. &#160;Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </p> </div> <div style="width: 624px"><p style="margin: 0px; text-align: justify">The following table provides a summary of changes in fair value of the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s Level 3 financial liabilities as of June 30, 2017 and December 31, 2016:</p> <p style="text-align: justify; margin: 0px">&#160;</p> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td colspan="2" style="width: 139px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Total</b></p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Balance, December 31, 2015</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Recognition of derivative liabilities upon initial valuation</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">40,892</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Change in fair value of derivative liabilities</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">35,403</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Conversions of derivative liabilities into equity instruments</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Balance, December 31, 2016</p></td> <td style="width: 36px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">76,295</p></td> <td style="width: 1px; height: 20px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Recognition of derivative liabilities upon initial valuation</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">89,226</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Change in fair value of derivative liabilities</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">(49,179)</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">Conversions of derivative liabilities into equity instruments</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 1px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 137px; vertical-align: bottom; border-bottom: #000000 2px solid; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #ffffff"> <p style="margin: 0px">&#160;</p></td></tr> <tr> <td style="width: 336px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Balance, June 30, 2017</p></td> <td style="width: 36px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 29px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 1px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px"><br /></p></td> <td style="width: 137px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">116,342</p></td> <td style="width: 1px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td></tr> </table> <p style="text-align: justify; margin: 0px">&#160;</p> </div> <div style="width: 624px"><p style="margin: 0px; text-align: justify">As of June 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:</p> <p style="text-align: justify; margin: 0px"><br /></p> <table cellpadding="0" cellspacing="0" align="center" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 275px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px">&#160;</p></td> <td style="width: 13px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 69px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Level 1</b></p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 68px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Level 2</b></p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 68px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Level 3</b></p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td colspan="2" style="width: 68px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Total</b></p></td></tr> <tr> <td style="width: 275px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">Derivative Liabilities</p></td> <td style="width: 13px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">116,342</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="margin: 0px">&#160;</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px; background-color: #cceeff"> <p style="text-align: right; margin: 0px">116,342</p></td></tr> <tr> <td style="width: 275px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Total</p></td> <td style="width: 13px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">-</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">116,342</p></td> <td style="width: 6px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 12px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;</p></td> <td style="width: 6px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="margin: 0px">$</p></td> <td style="width: 62px; vertical-align: bottom; border-bottom: #000000 3px double; padding: 0px; margin-top: 0px"> <p style="text-align: right; margin: 0px">116,342</p></td></tr> </table> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt">A summary of all employee options outstanding and exercisable under the plan as of June 30, 2017, and changes during the three months then ended is set forth below:</p> <p style="margin: 0px; line-height: 10.65pt"><br />&#160;</p> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 237px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Options</b></p></td> <td style="width: 90px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Shares</b></p></td> <td style="width: 114px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Weighted Average Exercise Price</b></p></td> <td style="width: 83px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Weighted Average Remaining Contractual &#160;Life (Years)</b></p></td> <td style="width: 85px; height: 80px; vertical-align: bottom; border-bottom: #000000 1px solid; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><b>Aggregate Intrinsic Value</b></p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: center; margin: 0px"><br /></p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px"><br /></p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Outstanding at the beginning of period </p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,185,000 </p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.16 </p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.66 </p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;&#160;&#160;Granted</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">--&#160;&#160;&#160;</p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">--</p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;&#160;&#160;Expired</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;--</p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</b></p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">&#160;&#160;&#160;Forfeited</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">-- &#160;&#160;</p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">--</p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Outstanding at the end of Period</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;2,185,000 </p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.17 </p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.16 </p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-- &#160;&#160;</p></td></tr> <tr> <td style="width: 237px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="margin: 0px">Exercisable at the end of Period</p></td> <td style="width: 90px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">1,836,667 </p></td> <td style="width: 114px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.17 </p></td> <td style="width: 83px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8.16 </p></td> <td style="width: 85px; height: 17px; vertical-align: bottom; padding: 0px; margin-top: 0px"> <p style="text-align: right; font-size: 9pt; margin: 0px">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;--&#160;&#160;&#160; </p></td></tr> </table> </div> <div style="width: 624px"> <p style="margin: 0px"><b><i>Condensed Consolidated Interim Financial Statements <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the <font style="font-family: Arial Unicode MS,Times New Roman">&#147;</font>Company<font style="font-family: Arial Unicode MS,Times New Roman">&#148;</font>). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report.&#160;In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.</p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Nature of Operations</i></b> <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through June 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.</p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Use of Estimates <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. &#160;Actual results could differ from those estimates.</p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Cash and Cash Equivalents <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. </p> </div> <div style="width: 624px"><p style="margin: 0px; line-height: 10.65pt"><b><i>Accounts Receivable <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> </i></b>Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. &#160;The balance in the allowance account was $102,140 and $102,140 in the periods ended June 30, 2017 and December 31, 2016, respectively. &#160;</p> </div> <div style="width: 624px"><p style="margin: 0px"><b>NOTE 2 <font style="font-family: Arial Unicode MS,Times New Roman">&#150;</font> GOING CONCERN </b></p> <p style="margin: 0px"><br /></p> <p style="margin: 0px">The Company continues to accumulate significant operating losses and has an accumulated deficit of $26,707,782 at June 30, 2017. &#160;These factors raise substantial doubt about the Company<font style="font-family: Arial Unicode MS,Times New Roman">&#146;</font>s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. The Company has relied on raising additional capital through the issuance of convertible notes payable &#160;However, there is no assurance that additional funding will be available on acceptable terms, if at all.</p> </div> 2653370 2196755 P3Y P10Y EX-101.SCH 6 flxt-20170630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - DERIVATIVE INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - STOCK OPTION PLANS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCK OPTION PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - GOING CONCERN (Details) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - CAPITAL STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 flxt-20170630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 flxt-20170630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 flxt-20170630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Range [Axis] Minimum [Member] Maximum [Member] Concentration Risk Benchmark [Axis] Sales [Member] Customer [Axis] Customer One [Member] Accounts Receivable [Member] Plan Name [Axis] 2005 Stock Incentive Plan [Member] Award Type [Axis] Stock Options [Member] Related Party [Axis] Director [Member] Title of Individual [Axis] Employee [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Four [Member] Exercise Price Range Three [Member] Chief Executive Officer [Member] Debt Instrument [Axis] Convertible Notes Payable to Related Party [Member] Derivative Classification [Member] Liability Class [Axis] Derivative Financial Instruments, Liabilities [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Convertible Notes Payable [Member] Debt Instrument [Axis] 2016 [Member] January 6 [Member] January 31 [Member] March 7 [Member] April 28 [Member] Officer [Member] New Convertible Notes Payable [Member] January 2 [Member] July 13 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net of allowance for bad debts of $102,140 and $102,140 Deposits and prepaid expenses Total Current Assets Long-Term Deposits Property and Equipment, net of accumulated depreciation of $587,886 and $586,787 Patents and Proprietary Technology, net of accumulated amortization of $906,571 and $876,037 Goodwill Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable Accounts payable - related party Accrued liabilities Convertible notes payable Convertible notes payable to related party, net Derivative liabilities Total current liabilities Long-term Liabilities Convertible notes payable, net Total Liabilities Stockholders' Equity Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding Common stock - $0.001 par value; 100,000,000 shares authorized; 78,363,464 shares and 78,363,464 shares issued and outstanding Additional paid-in capital Accumulated deficit Total Stockholders' Equity Total Liabilities and Stockholders' Equity Accounts receivable, allowance for bad debts Property and Equipment, accumulated depreciation Patents and Proprietary Technology, accumulated amortization Preferred stock, par value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Design, Contract and Testing Revenue Operating Costs and Expenses Amortization of patents and proprietary proprietary technology Cost of revenue Administrative and marketing expense Research and development expense Total Operating Costs and Expenses Net Operating Loss Other Income and Expenses Interest expense Interest income Gain(Loss) on derivative Net Other Income (Expense) Net Loss Basic and Diluted Loss per Common Share Basic and Diluted Weighted-Average Common Shares Outstanding Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Stock subscription for compensation Stock-based compensation expense Amortization of patents and proprietary technology Amortization of discount on note payable Depreciation Change in fair value of derivative liabilities Interest expense recognized for derivative liabilities Changes in operating assets and liabilities: Accounts receivable Deposits and prepaid expenses Accounts payable Accounts payable - related parties Accrued liabilities Net Cash Used in Operating Activities Cash Flows from Investing Activities: Note receivable interest income Net Cash Used in Investing Activities Cash Flows from Financing Activities: Proceeds from bank overdrafts Proceeds from borrowings under convertible note payable - related party Proceeds from borrowings under convertible note payable Net Cash Provided by Financing Activities Net Change in Cash and Cash Equivalents Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents at End of Period Supplemental Cash Flow Information: Cash paid for income taxes Cash paid for interest Supplemental Disclosure on Noncash Investing and Financing Activities Recognition of discounts on convertible notes payable SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN[Abstract] GOING CONCERN DERIVATIVE INSTRUMENTS [Abstract] DERIVATIVE INSTRUMENTS STOCK OPTION PLANS [Abstract] STOCK OPTION PLANS CAPITAL STOCK [Abstract] CAPITAL STOCK COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES RELATED PARTY TRANSACTIONS [Abstract] RELATED PARTY TRANSACTIONS SUBSEQUENT EVENTS [Abstract] SUBSEQUENT EVENTS Condensed Consolidated Interim Financial Statements Nature of Operations Use of Estimates Cash and Cash Equivalents. Fair Value of Financial Instruments Accounts Receivable Inventories Business Condition Property and Equipment. Valuation of Long-lived Assets Intangible Assets Research and Development Goodwill Revenue Recognition Stock-Based Compensation Basic and Diluted Loss Per Share Concentrations and Credit Risk Income Tax Recent Accounting Pronouncements Derivative Instruments Tables Schedule of Changes in Level 3 Financial Liabilities Schedule of Liabilities Measured at Fair Value on Recurring Basis Schedule of Stock Option Activity Nature Of Business [Table] Nature Of Business [Line Items] Property and equipment, useful lives Intangible assets, useful lives Anti-dilutive securities excluded from computation of earnings per share amount Risk percentage Going Concern Details Statement [Table] Statement [Line Items] Report Date [Axis] Derivative liabilities Loss on change in fair value of derivative liabilities Interest expense in connection with recognition of derivative liabilities Dividend yield Expected volatility Risk-free interest rate Expected life Debt instrument, face amount Debt instrument, issuance date Debt instrument, maturity date range end Debt instrument, maturity date Debt instrument, interest rate Debt instrument, default rate Debt instrument, collateral amount Convertible notes payable, principal amount outstanding Accrued interest Interest expense Convertible notes payable, balance Fair value of common stock advance Fair value of common stock Intrinsic value Beneficial conversion feature Discount balance Accrued interest Debt instrument, conversion price Drew amount of note Balance Recognition of derivative liabilities upon initial valuation Change in fair value of derivative liabilities Conversions of derivative liabilities into equity instruments Balance Liabilities, fair value Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Effective term Shares authorized Issuance of options for purchase of common shares Options granted during period Exercise price of stock options granted Exercise price of stock options granted, minimum Exercise price of stock options granted, maximum Option vesting period Option expiration period Option pricing assumptions Market value per share at time of issuance Expected term Risk-free interest rate Dividend yield Expected volatility Weighted-average fair value of options granted Option forfeiture rate Stock-based compensation expense Options outstanding Unrecognized compensation cost related to employee stock options Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] Shares Outstanding at the beginning of period Granted Expired Forfeited Outstanding at the end of Period Exercisable at the end of the Period Weighted Average Exercise Price Outstanding at the beginning of period Granted Expired Forfeited Outstanding at the end of Period Exercisable at the end of Period Weighted Average Remaining Contractual Life (Years) Outstanding at the beginning of period Granted Expired Forfeited Outstanding at the end of Period Exercisable at the end of Period Aggregate Intrinsic Value Outstanding at the beginning of period Granted Expired Forfeited Outstanding at the end of Period Exercisable at the end of the Period Stockholders' Equity Note [Abstract] Debt conversion, date Conversion of convertible notes, amount Conversion of convertible notes, interest accrued and unpaid, amount Conversion of convertible notes, shares issued Average conversion price for converted debt instruments Stock issued Total common shares issued during period Shares issued in settlement of accrued liabilities, shares Accrued liabilities extinguished from issuance of restricted common stock Commitments and Contingencies Disclosure [Abstract] Operating lease expiration period Lease, monthly payment in 2015 Lease, monthly payment in 2016 Lease, monthly payment in 2017 Deposit received from related party for commercial beds Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Maximum borrowing capacity Amount drawn against note Annual interest rate Conversion price Maturity date Promissory note issued Accrued liabilities extinguished from issuance of restricted common stock. April 28 [Member] The accounting policy relating to the financial condition of the company. Fair value of common stock per share. Convertible notes payable, principal amount outstanding. Convertible Notes Payable Related Party [Member] Customer One [Member] The average conversion price for converted debt instruments. The value of the accrued interest of the original debt that is being converted into in a noncash (or part noncash) transaction. This item represents the default rate of debt instrument. Derivative Classification [Member] Derivative instrument. Drew amount of note. Employee [Member] Exercise price range four [Member] Exercise price range one [Member] Exercise price range three [Member] Exercise price range two [Member] Intrinsic value of common stock. January 6 [Member] January 31 [Member] March 7 [Member] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Information contained within the Nature of Business disclosure. Disclosure of accounting policy for nature of operations. Note receivable interest income. Lease, monthly payment in 2015. Amount of required minimum monthly rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Amount of required minimum monthly rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Recognition of discounts on convertible notes payable. Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Aggregate intrinsic value of options that expired during the period. Aggregate intrinsic value of options forfeited during the period. Aggregate intrinsic value of options granted during the period. Represents the rate at which option awards are expected to be forfeited. Weighted average remaining contractual life of options that expired during the period. Weighted average remaining contractual life of options forfeited during the period. Options granted, weighted average remaining contractual term. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Represents information pertaining to 2005 Stock Incentive Plan (the Plan). The term of the stock incentive plan unless otherwise terminated. Stock subscription for compensation. Total common shares issued during period. 2016 [Member] New Convertible Notes Payable [Member] June Two [Member] July Thirteen [Member] Assets, Current Assets Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations NoteReceivableInterestIncome Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Derivative Liability, Current Interest Expense, Debt Interest Payable Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Allocated Share-based Compensation Expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExpiredWeightedAverageRemainingContractualTerm1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredIntrinsicValue ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Long-term Line of Credit EX-101.PRE 10 flxt-20170630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2017
Aug. 14, 2017
Document And Entity Information    
Entity Registrant Name FLEXPOINT SENSOR SYSTEMS INC  
Entity Central Index Key 0000925660  
Document Type 10-Q  
Document Period End Date Jun. 30, 2017  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   78,363,464
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2017  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current Assets    
Cash and cash equivalents $ 686
Accounts receivable, net of allowance for bad debts of $102,140 and $102,140 119,249 84,499
Deposits and prepaid expenses 9,368 9,348
Total Current Assets 129,303 93,847
Long-Term Deposits 6,550 6,550
Property and Equipment, net of accumulated depreciation of $587,886 and $586,787 9,704 10,823
Patents and Proprietary Technology, net of accumulated amortization of $906,571 and $876,037 65,824 96,358
Goodwill 4,896,917 4,896,917
Total Assets 5,108,301 5,104,495
Current Liabilities    
Accounts payable 186,279 172,602
Accounts payable - related party 15,594 1,420
Accrued liabilities 975,449 741,778
Convertible notes payable 1,324,660 1,184,660
Convertible notes payable to related party, net 35,046 20,000
Derivative liabilities 116,342 76,295
Total current liabilities 2,653,370 2,196,755
Long-term Liabilities    
Convertible notes payable, net 22,272
Total Liabilities 2,675,642 2,196,755
Stockholders' Equity    
Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding
Common stock - $0.001 par value; 100,000,000 shares authorized; 78,363,464 shares and 78,363,464 shares issued and outstanding 78,363 78,363
Additional paid-in capital 29,062,078 29,052,188
Accumulated deficit (26,707,782) (26,222,811)
Total Stockholders' Equity 2,432,659 2,907,740
Total Liabilities and Stockholders' Equity $ 5,108,301 $ 5,104,495
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Statement of Financial Position [Abstract]    
Accounts receivable, allowance for bad debts $ 102,140 $ 102,140
Property and Equipment, accumulated depreciation 587,886 586,787
Patents and Proprietary Technology, accumulated amortization $ 906,571 $ 876,037
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value per share $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 78,363,464 78,363,464
Common stock, shares outstanding 78,363,464 78,363,464
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]        
Design, Contract and Testing Revenue $ 154,636 $ 93,039 $ 215,701 $ 128,205
Operating Costs and Expenses        
Amortization of patents and proprietary proprietary technology 12,110 22,346 30,533 46,087
Cost of revenue 30,892 1,166 34,641 2,510
Administrative and marketing expense 189,738 175,935 354,851 353,356
Research and development expense 85,143 79,281 164,509 159,340
Total Operating Costs and Expenses 317,883 278,728 584,534 561,293
Net Operating Loss (163,247) (185,689) (368,833) (433,088)
Other Income and Expenses        
Interest expense (63,730) (230,707) (165,340) (454,598)
Interest income 11 1,915 23 3,830
Gain(Loss) on derivative 33,492 49,179
Net Other Income (Expense) (30,227) (228,792) (116,138) (450,768)
Net Loss $ (193,474) $ (414,481) $ (484,971) $ (883,856)
Basic and Diluted Loss per Common Share $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Basic and Diluted Weighted-Average Common Shares Outstanding 78,363,464 71,627,114 78,363,464 71,627,114
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:    
Net loss $ (484,971) $ (883,856)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock subscription for compensation 1,000
Stock-based compensation expense 9,890 16,802
Amortization of patents and proprietary technology 30,533 46,087
Amortization of discount on note payable 3,246 405,521
Depreciation 1,120
Change in fair value of derivative liabilities (49,179)
Interest expense recognized for derivative liabilities 63,298
Changes in operating assets and liabilities:    
Accounts receivable (34,750) (85,527)
Deposits and prepaid expenses (20) 2,625
Accounts payable 13,674 7,943
Accounts payable - related parties 14,174 516
Accrued liabilities 214,604 186,892
Net Cash Used in Operating Activities (218,381) (301,997)
Cash Flows from Investing Activities:    
Note receivable interest income (3,807)
Net Cash Used in Investing Activities (3,807)
Cash Flows from Financing Activities:    
Proceeds from bank overdrafts 19,067 35,870
Proceeds from borrowings under convertible note payable - related party 20,000
Proceeds from borrowings under convertible note payable 180,000 250,000
Net Cash Provided by Financing Activities 219,667 285,870
Net Change in Cash and Cash Equivalents 686 (19,934)
Cash and Cash Equivalents at Beginning of Period 22,706
Cash and Cash Equivalents at End of Period 686 2,772
Supplemental Cash Flow Information:    
Cash paid for income taxes
Cash paid for interest
Supplemental Disclosure on Noncash Investing and Financing Activities    
Recognition of discounts on convertible notes payable $ 25,928 $ 56,750
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Condensed Consolidated Interim Financial Statements The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the Company). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Companys Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Companys significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.


Nature of Operations Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Companys activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Companys operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through June 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.


Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates.


Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.


Fair Value MeasurementsThe fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the partys own credit risk.

 

Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

 

The carrying value of the Companys cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.

 

The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.


Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances.  The balance in the allowance account was $102,140 and $102,140 in the periods ended June 30, 2017 and December 31, 2016, respectively.  


Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.


Valuation of Long-lived Assets The carrying values of the Companys long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the period ended June 30, 2017 and during the period ended June 30, 2016.  Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.


Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.  Under similar analysis there was no impairment charge taken during the period ended June 30, 2017 and during the period ended June 30, 2016.


Research and Development Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.


Goodwill Goodwill represents the excess of the Companys reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or ASC) 350-20 Intangibles Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Companys assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.


Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.  The Company does not provide extended warranties or guarantees on its products.


Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.   All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended June 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $9,890 and $16,802, respectively.


Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At June 30, 2017 and June 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 27,986,602 and 21,648,704, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.


Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable.  During the six month period ended June 30, 2017, a customer who manufacturers toys represented 45% of sales and represented 11% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Companys technologies.  


Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized


Recent Accounting Pronouncements - In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-09, "Stock Compensation - Scope of Modification Accounting". This ASU requires all modifications to be accounted for as a modification unless the fair value, vesting conditions and classification of the award as equity or liability are the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective for fiscal years beginning after December 15, 2017 and for interim periods therein. The Company does not believe this ASU will have a material impact on its consolidated financial position, results of operation or cash flows.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
GOING CONCERN
6 Months Ended
Jun. 30, 2017
GOING CONCERN[Abstract]  
GOING CONCERN

NOTE 2 GOING CONCERN


The Company continues to accumulate significant operating losses and has an accumulated deficit of $26,707,782 at June 30, 2017.  These factors raise substantial doubt about the Companys ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. The Company has relied on raising additional capital through the issuance of convertible notes payable  However, there is no assurance that additional funding will be available on acceptable terms, if at all.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
DERIVATIVE INSTRUMENTS
6 Months Ended
Jun. 30, 2017
DERIVATIVE INSTRUMENTS [Abstract]  
DERIVATIVE INSTRUMENTS

NOTE 3 DERIVATIVE INSTRUMENTS


The derivative liability as of June 30, 2017, in the amount of $116,342 has a Level 3 fair value classification. The following table provides a summary of changes in fair value of the Companys Level 3 financial liabilities as of June 30, 2017 and December 31, 2016:

 

 

 

 

 

Total

 

Balance, December 31, 2015

 

 



-

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

40,892

 

Change in fair value of derivative liabilities

 

 

 

 

35,403

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, December 31, 2016

 

 

 

 

76,295

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

89,226

 

Change in fair value of derivative liabilities

 

 

 

 

(49,179)

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, June 30, 2017

 

 



116,342

 

 

During the year ended 2016 and the period ended June 30, 2017, the Company issued convertible promissory notes which are convertible into common stock. Due to the Companys lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle all convertible instruments.  The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.

 

At June 30, 2017, the Company marked to market the fair value of the derivatives and determined a fair value of $116,342. The Company recorded a gain from change in fair value of derivatives of $49,179 for the six month period ended June 30, 2017. During the six months ended June 30, 2017, the Company recorded additional interest expense of $63,298 and debt discounts of $25,928 in connection with the recognition of derivative liabilities. The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 114.57% to 128.15%, (3) weighted average risk-free interest rate of 0.76% to 1.14% (4) expected life of 0.50 to 1.08 years, and (5) the quoted market price of the Companys common stock at each valuation date.

 

In accordance ASC 840-15-25, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.

  

As of June 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:


 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

Derivative Liabilities

 

 

-

 

 

 

-

 

 

 

116,342

 

 

 

116,342

Total

 

$

-

 

 

$

-

 

 

$

116,342

 

 

$

116,342


Convertible Notes Payable


The Company entered into a new promissory note for up to $300,000 from a third party on May 25, 2017.  The note has an annual interest rate of 10% and is secured by the Companys equipment.  The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of July 31, 2018.  The Company drew $40,000 against that note on June 2, 2017 and $40,000 on July 13, 2017.  


The Company entered into a convertible promissory note for up to $300,000 from a third party on July 1, 2016.  The note has an annual interest rate of 10% and is secured by the Companys equipment.  The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.  The Company drew $160,000 against that note during 2016 and $40,000 on January 6, 2017; $40,000 on January 31, 2017 $40,000 on March 7, 2017 and the balance of $20,000 on April 28, 2017.


On August 8, 2011, the Company entered into a convertible note payable with a former Company Director for $40,000. This note was due on December 31, 2015, bears an annual interest rate of 10% annual interest and is secured by business equipment.


Convertible Note Payable Related Party


On April 17, 2017 the Company issued a note for $20,000 to an officer of the Company.  The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2017.  The note is secured by all of the Companys business equipment.


On July 1, 2016 and September 22, 2016, the Company issued two promissory notes for $10,000 each to an officer of the Company.  The notes bear interest at the rate of 10%, have a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.  Since the fair value of the common stock at the date of the July 1, 2016 advance was $0.07, no BCF was recorded.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK OPTION PLANS
6 Months Ended
Jun. 30, 2017
STOCK OPTION PLANS [Abstract]  
STOCK OPTION PLANS

NOTE 4 STOCK OPTION PLANS


On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Companys trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares.  The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.


On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Companys common stock.  Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees.  Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share.  Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively.  We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.


Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.  Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share.  The options vest over three years and expire 10 years from the date of grant.  The Company used the following assumptions in estimating the fair value of the options granted:


·

Market value at the time of issuance Range of $0.14 to 2.07

·

Expected term Range of 3.7 years to 10.0 years

·

Risk-free interest rate Range of 1.60% to 4.93%

·

Dividend yield 0%

·

Expected volatility 200% to 424%

·

Weighted-average fair value - $0.16 to $2.07


During the six months ended June 30, 2017, the Company recognized a total of $9,890 of stock-based compensation expense, leaving $10,052 in unrecognized expense as of June 30, 2017. During the six months ended June 30, 2016, the Company recognized $16,802 in stock-based compensation expense. There were 2,185,000 and 2,185,000 employee stock options outstanding at June 30, 2017 and December 31, 2016, respectively.  


A summary of all employee options outstanding and exercisable under the plan as of June 30, 2017, and changes during the three months then ended is set forth below:


 

Options

Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual  Life (Years)

Aggregate Intrinsic Value






Outstanding at the beginning of period

         2,185,000

 $                0.16

             8.66

 $              --   

   Granted

--   

--

                   --   

                 --   

   Expired

                     --   

                             --

                   --   

                 --   

   Forfeited

--   

--

                   --   

                --   

Outstanding at the end of Period

       2,185,000

 $                 0.17

             8.16

$              --   

Exercisable at the end of Period

1,836,667

 $                 0.17

             8.16

 $              --   

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
CAPITAL STOCK
6 Months Ended
Jun. 30, 2017
CAPITAL STOCK [Abstract]  
CAPITAL STOCK

NOTE 4 CAPITAL STOCK


Preferred Stock There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized.  At June 30, 2017 and December 31, 2016, there were no shares of preferred stock issued or outstanding.


Common Stock There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized.  No shares of stock were issued during the six months ended June 30, 2017.  

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 5 - COMMITMENTS AND CONTINGENCIES


The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017.  Either party may terminate the lease upon 90 day written notice.  Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), $9,300 per month in 2016 and $9,600 per month in 2017.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2017
RELATED PARTY TRANSACTIONS [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 RELATED PARTY TRANSACTIONS


At June 30, 2017 and December 31, 2016, the Company had accounts payable of $15,594 and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2017
SUBSEQUENT EVENTS [Abstract]  
SUBSEQUENT EVENTS

NOTE 7- SUBSEQUENT EVENTS


On July 13, 2017 the Company drew $40,000 against a convertible promissory note for up to $300,000 from a third party, the proceeds of which will be used to fund operating expenses. The note has an annual interest rate of 10% and is secured by the Companys equipment. The note has a conversion feature for restricted common shares at $.07 per share.  

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]  
Condensed Consolidated Interim Financial Statements

Condensed Consolidated Interim Financial Statements The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the Company). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Companys Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Companys significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.

Nature of Operations

Nature of Operations Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Companys activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Companys operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through June 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.

Use of Estimates

Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates.

Cash and Cash Equivalents.

Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.

Fair Value of Financial Instruments

Fair Value MeasurementsThe fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the partys own credit risk.

 

Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

 

The carrying value of the Companys cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.

 

The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.

Accounts Receivable

Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design and development engineering generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances.  The balance in the allowance account was $102,140 and $102,140 in the periods ended June 30, 2017 and December 31, 2016, respectively.  

Property and Equipment.

Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.

Valuation of Long-lived Assets

Valuation of Long-lived Assets The carrying values of the Companys long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the period ended June 30, 2017 and during the period ended June 30, 2016.  Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.

Intangible Assets

Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.  Under similar analysis there was no impairment charge taken during the period ended June 30, 2017 and during the period ended June 30, 2016.

Research and Development

Research and Development Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.

Goodwill

Goodwill Goodwill represents the excess of the Companys reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or ASC) 350-20 Intangibles Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Companys assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.

Revenue Recognition

Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.  The Company does not provide extended warranties or guarantees on its products.

Stock-Based Compensation

Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.   All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended June 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $9,890 and $16,802, respectively.

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At June 30, 2017 and June 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 27,986,602 and 21,648,704, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.

Concentrations and Credit Risk

Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable.  During the six month period ended June 30, 2017, a customer who manufacturers toys represented 45% of sales and represented 11% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Companys technologies.  

Income Tax

Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized

Recent Accounting Pronouncements

Recent Accounting Pronouncements - In May 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-09, "Stock Compensation - Scope of Modification Accounting". This ASU requires all modifications to be accounted for as a modification unless the fair value, vesting conditions and classification of the award as equity or liability are the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective for fiscal years beginning after December 15, 2017 and for interim periods therein. The Company does not believe this ASU will have a material impact on its consolidated financial position, results of operation or cash flows.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
DERIVATIVE INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2017
Derivative Instruments Tables  
Schedule of Changes in Level 3 Financial Liabilities

The following table provides a summary of changes in fair value of the Companys Level 3 financial liabilities as of June 30, 2017 and December 31, 2016:

 

 

 

 

 

Total

 

Balance, December 31, 2015

 

 



-

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

40,892

 

Change in fair value of derivative liabilities

 

 

 

 

35,403

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, December 31, 2016

 

 

 

 

76,295

 

Recognition of derivative liabilities upon initial valuation

 

 

 

 

89,226

 

Change in fair value of derivative liabilities

 

 

 

 

(49,179)

 

Conversions of derivative liabilities into equity instruments

 

 

 

 

-

 

Balance, June 30, 2017

 

 



116,342

 

 

Schedule of Liabilities Measured at Fair Value on Recurring Basis

As of June 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:


 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

Derivative Liabilities

 

 

-

 

 

 

-

 

 

 

116,342

 

 

 

116,342

Total

 

$

-

 

 

$

-

 

 

$

116,342

 

 

$

116,342

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK OPTION PLANS (Tables)
6 Months Ended
Jun. 30, 2017
STOCK OPTION PLANS [Abstract]  
Schedule of Stock Option Activity

A summary of all employee options outstanding and exercisable under the plan as of June 30, 2017, and changes during the three months then ended is set forth below:


 

Options

Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual  Life (Years)

Aggregate Intrinsic Value






Outstanding at the beginning of period

         2,185,000

 $                0.16

             8.66

 $              --   

   Granted

--   

--

                   --   

                 --   

   Expired

                     --   

                             --

                   --   

                 --   

   Forfeited

--   

--

                   --   

                --   

Outstanding at the end of Period

       2,185,000

 $                 0.17

             8.16

$              --   

Exercisable at the end of Period

1,836,667

 $                 0.17

             8.16

 $              --   

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Nature Of Business [Line Items]      
Accounts receivable, allowance for bad debts $ 102,140   $ 102,140
Stock-based compensation expense $ 9,890 $ 16,802  
Anti-dilutive securities excluded from computation of earnings per share amount 27,986,602 21,648,704  
Sales [Member] | Customer One [Member]      
Nature Of Business [Line Items]      
Risk percentage 45.00%    
Accounts Receivable [Member] | Customer One [Member]      
Nature Of Business [Line Items]      
Risk percentage 11.00%    
Minimum [Member]      
Nature Of Business [Line Items]      
Property and equipment, useful lives P3Y    
Intangible assets, useful lives 5 years    
Maximum [Member]      
Nature Of Business [Line Items]      
Property and equipment, useful lives P10Y    
Intangible assets, useful lives 15 years    
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
GOING CONCERN (Details) - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Going Concern Details    
Accumulated deficit $ (26,707,782) $ (26,222,811)
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
DERIVATIVE INSTRUMENTS (Narrative) (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 08, 2011
Sep. 30, 2016
Jul. 31, 2016
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Sep. 22, 2016
Derivative liabilities       $ 116,342   $ 116,342      
Loss on change in fair value of derivative liabilities       33,492 49,179    
Interest expense in connection with recognition of derivative liabilities           63,298      
Proceeds from borrowings under convertible note payable           180,000 $ 250,000    
Convertible notes payable, balance       22,272   22,272    
Discount balance       25,928   25,928      
Convertible Notes Payable [Member]                  
Debt instrument, face amount       $ 300,000   $ 300,000      
Debt instrument, issuance date           Jul. 01, 2016      
Debt instrument, maturity date           Dec. 31, 2016      
Debt instrument, interest rate       10.00%   10.00%   10.00%  
Debt instrument, conversion price       $ 0.07   $ 0.07      
Convertible Notes Payable [Member] | Director [Member]                  
Debt instrument, face amount $ 40,000                
Debt instrument, maturity date Dec. 31, 2015                
Debt instrument, interest rate 10.00%                
Convertible Notes Payable [Member] | January 2 [Member]                  
Proceeds from borrowings under convertible note payable           $ 40,000      
Convertible Notes Payable [Member] | July 13 [Member]                  
Proceeds from borrowings under convertible note payable           40,000      
Convertible Notes Payable [Member] | 2016 [Member]                  
Proceeds from borrowings under convertible note payable           160,000      
Convertible Notes Payable [Member] | January 6 [Member]                  
Proceeds from borrowings under convertible note payable           40,000      
Convertible Notes Payable [Member] | January 31 [Member]                  
Proceeds from borrowings under convertible note payable           40,000      
Convertible Notes Payable [Member] | March 7 [Member]                  
Proceeds from borrowings under convertible note payable           40,000      
Convertible Notes Payable [Member] | April 28 [Member]                  
Convertible notes payable, balance       $ 20,000   20,000      
Convertible Notes Payable to Related Party [Member]                  
Debt instrument, face amount       $ 20,000   $ 20,000      
Debt instrument, interest rate       8.00%   8.00%      
Debt instrument, conversion price       $ 0.07   $ 0.07      
Convertible Notes Payable to Related Party [Member] | Officer [Member]                  
Debt instrument, face amount   $ 10,000 $ 20,000            
Debt instrument, issuance date   Sep. 22, 2016 Jul. 01, 2016            
Debt instrument, maturity date   Dec. 31, 2016 Dec. 31, 2016            
Debt instrument, interest rate   10.00% 8.00%            
Intrinsic value   $ 0.01              
Beneficial conversion feature   $ 1,286              
Debt instrument, conversion price   $ 0.07 $ 0.07           $ 0.08
New Convertible Notes Payable [Member]                  
Debt instrument, face amount       $ 300,000   $ 300,000      
Debt instrument, issuance date           May 25, 2017      
Debt instrument, maturity date           Jul. 31, 2018      
Debt instrument, interest rate       10.00%   10.00%      
Debt instrument, conversion price       $ 0.07   $ 0.07      
Derivative Classification [Member]                  
Dividend yield           0.00%      
Derivative Classification [Member] | Minimum [Member]                  
Expected volatility           114.57%      
Risk-free interest rate           0.76%      
Expected life           6 months      
Derivative Classification [Member] | Maximum [Member]                  
Expected volatility           128.15%      
Risk-free interest rate           1.14%      
Expected life           1 year 29 days      
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) - Derivative Financial Instruments, Liabilities [Member] - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2017
Dec. 31, 2016
Balance $ 76,295
Recognition of derivative liabilities upon initial valuation 89,226 40,892
Change in fair value of derivative liabilities (49,179) 35,403
Conversions of derivative liabilities into equity instruments
Balance $ 116,342 $ 76,295
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) - Fair Value, Measurements, Recurring [Member]
Jun. 30, 2017
USD ($)
Liabilities, fair value $ 116,342
Derivative Financial Instruments, Liabilities [Member]  
Liabilities, fair value 116,342
Level 1 [Member]  
Liabilities, fair value
Level 1 [Member] | Derivative Financial Instruments, Liabilities [Member]  
Liabilities, fair value
Level 2 [Member]  
Liabilities, fair value
Level 2 [Member] | Derivative Financial Instruments, Liabilities [Member]  
Liabilities, fair value
Level 3 [Member]  
Liabilities, fair value 116,342
Level 3 [Member] | Derivative Financial Instruments, Liabilities [Member]  
Liabilities, fair value $ 116,342
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK OPTION PLANS (Narrative) (Details) - USD ($)
6 Months Ended 136 Months Ended
Aug. 24, 2015
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options granted during period        
Option pricing assumptions          
Weighted-average fair value of options granted        
Stock-based compensation expense   $ 9,890 $ 16,802    
Options outstanding   2,185,000   2,185,000  
Unrecognized compensation cost related to employee stock options   $ 10,052      
2005 Stock Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Effective term   10 years      
Shares authorized   2,500,000      
2005 Stock Incentive Plan [Member] | Stock Options [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 2,185,000        
Options granted during period       3,096,000  
Exercise price of stock options granted, minimum       $ 0.14  
Exercise price of stock options granted, maximum       $ 2.07  
Option vesting period 2 years 4 months     3 years  
Option expiration period       10 years  
Option pricing assumptions          
Dividend yield       0.00%  
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Director [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 1,960,000        
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Employee [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 225,000        
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Exercise Price Range One [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 640,000        
Exercise price of stock options granted $ 0.14        
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Exercise Price Range Two [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 500,000        
Exercise price of stock options granted $ 0.15        
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Exercise Price Range Three [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 995,000        
Exercise price of stock options granted $ 0.20        
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Exercise Price Range Four [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Issuance of options for purchase of common shares 50,000        
Exercise price of stock options granted $ 0.25        
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Minimum [Member]          
Option pricing assumptions          
Market value per share at time of issuance         $ 0.14
Expected term       3 years 8 months 12 days  
Risk-free interest rate       1.60%  
Expected volatility       200.00%  
Weighted-average fair value of options granted       $ 0.16  
2005 Stock Incentive Plan [Member] | Stock Options [Member] | Maximum [Member]          
Option pricing assumptions          
Market value per share at time of issuance         $ 2.07
Expected term       10 years  
Risk-free interest rate       4.93%  
Expected volatility       424.00%  
Weighted-average fair value of options granted       $ 2.07  
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details)
6 Months Ended
Jun. 30, 2017
USD ($)
$ / shares
shares
Shares  
Outstanding at the beginning of period | shares 2,185,000
Granted | shares
Expired | shares
Forfeited | shares
Outstanding at the end of Period | shares 2,185,000
Exercisable at the end of the Period | shares 1,836,667
Weighted Average Exercise Price  
Outstanding at the beginning of period | $ / shares $ 0.16
Granted | $ / shares
Expired | $ / shares
Forfeited | $ / shares
Outstanding at the end of Period | $ / shares 0.17
Exercisable at the end of Period | $ / shares $ 0.17
Weighted Average Remaining Contractual Life (Years)  
Outstanding at the beginning of period 8 years 7 months 28 days
Outstanding at the end of Period 8 years 1 month 27 days
Exercisable at the end of Period 8 years 1 month 27 days
Outstanding at the beginning of period | $
Granted | $
Expired | $
Forfeited | $
Outstanding at the end of Period | $
Exercisable at the end of the Period | $
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
CAPITAL STOCK (Details) - $ / shares
Jun. 30, 2017
Dec. 31, 2016
CAPITAL STOCK [Abstract]    
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, par value per share $ 0.001 $ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized 100,000,000 100,000,000
Common stock, par value per share $ 0.001 $ 0.001
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES (Details)
6 Months Ended
Jun. 30, 2017
USD ($)
COMMITMENTS AND CONTINGENCIES [Abstract]  
Operating lease expiration period Dec. 31, 2017
Lease, monthly payment in 2015 $ 8,950
Lease, monthly payment in 2016 9,300
Lease, monthly payment in 2017 $ 9,600
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
RELATED PARTY TRANSACTIONS (Details) - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Related Party Transaction [Line Items]    
Accounts payable - related party $ 15,594 $ 1,420
Chief Executive Officer [Member]    
Related Party Transaction [Line Items]    
Accounts payable - related party $ 15,594 $ 1,420
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
SUBSEQUENT EVENTS (Details) - USD ($)
6 Months Ended
Jul. 13, 2017
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Proceeds from borrowings under convertible note payable   $ 180,000 $ 250,000  
Convertible Notes Payable [Member]        
Annual interest rate   10.00%   10.00%
Conversion price   $ 0.07    
Maturity date   Dec. 31, 2016    
Debt instrument, face amount   $ 300,000    
Convertible Notes Payable [Member] | Subsequent Event [Member]        
Annual interest rate 10.00%      
Conversion price $ 0.07      
Proceeds from borrowings under convertible note payable $ 40,000      
Debt instrument, face amount $ 300,000      
EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

XML 39 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 67 168 1 false 33 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://flexpoint.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://flexpoint.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://flexpoint.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://flexpoint.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://flexpoint.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://flexpoint.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 6 false false R7.htm 00000007 - Disclosure - GOING CONCERN Sheet http://flexpoint.com/role/GoingConcern GOING CONCERN Notes 7 false false R8.htm 00000008 - Disclosure - DERIVATIVE INSTRUMENTS Sheet http://flexpoint.com/role/DerivativeInstruments DERIVATIVE INSTRUMENTS Notes 8 false false R9.htm 00000009 - Disclosure - STOCK OPTION PLANS Sheet http://flexpoint.com/role/StockOptionPlans STOCK OPTION PLANS Notes 9 false false R10.htm 00000010 - Disclosure - CAPITAL STOCK Sheet http://flexpoint.com/role/CapitalStock CAPITAL STOCK Notes 10 false false R11.htm 00000011 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://flexpoint.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://flexpoint.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - SUBSEQUENT EVENTS Sheet http://flexpoint.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 13 false false R14.htm 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://flexpoint.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 14 false false R15.htm 00000015 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://flexpoint.com/role/DerivativeInstrumentsTables DERIVATIVE INSTRUMENTS (Tables) Tables http://flexpoint.com/role/DerivativeInstruments 15 false false R16.htm 00000016 - Disclosure - STOCK OPTION PLANS (Tables) Sheet http://flexpoint.com/role/StockOptionPlansTables STOCK OPTION PLANS (Tables) Tables http://flexpoint.com/role/StockOptionPlans 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://flexpoint.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://flexpoint.com/role/SummaryOfSignificantAccountingPoliciesPolicies 17 false false R18.htm 00000018 - Disclosure - GOING CONCERN (Details) Sheet http://flexpoint.com/role/GoingConcernDetails GOING CONCERN (Details) Details http://flexpoint.com/role/GoingConcern 18 false false R19.htm 00000019 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details) Sheet http://flexpoint.com/role/DerivativeInstrumentsNarrativeDetails DERIVATIVE INSTRUMENTS (Narrative) (Details) Details http://flexpoint.com/role/DerivativeInstrumentsTables 19 false false R20.htm 00000020 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) Sheet http://flexpoint.com/role/DerivativeInstrumentsScheduleOfChangesInLevel3FinancialLiabilitiesDetails DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) Details http://flexpoint.com/role/DerivativeInstrumentsTables 20 false false R21.htm 00000021 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) Sheet http://flexpoint.com/role/DerivativeInstrumentsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) Details http://flexpoint.com/role/DerivativeInstrumentsTables 21 false false R22.htm 00000022 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) Sheet http://flexpoint.com/role/StockOptionPlansNarrativeDetails STOCK OPTION PLANS (Narrative) (Details) Details http://flexpoint.com/role/StockOptionPlansTables 22 false false R23.htm 00000023 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Sheet http://flexpoint.com/role/StockOptionPlansScheduleOfStockOptionActivityDetails STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Details http://flexpoint.com/role/StockOptionPlansTables 23 false false R24.htm 00000024 - Disclosure - CAPITAL STOCK (Details) Sheet http://flexpoint.com/role/CapitalStockDetails CAPITAL STOCK (Details) Details http://flexpoint.com/role/CapitalStock 24 false false R25.htm 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://flexpoint.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://flexpoint.com/role/CommitmentsAndContingencies 25 false false R26.htm 00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://flexpoint.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://flexpoint.com/role/RelatedPartyTransactions 26 false false R27.htm 00000027 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://flexpoint.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://flexpoint.com/role/SubsequentEvents 27 false false All Reports Book All Reports flxt-20170630.xml flxt-20170630.xsd flxt-20170630_cal.xml flxt-20170630_def.xml flxt-20170630_lab.xml flxt-20170630_pre.xml true true ZIP 44 0001548123-17-000202-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001548123-17-000202-xbrl.zip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�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end